US20140288389A1 - Systems and Methods for Performing Neurophysiologic Assessments with Pressure Monitoring - Google Patents
Systems and Methods for Performing Neurophysiologic Assessments with Pressure Monitoring Download PDFInfo
- Publication number
- US20140288389A1 US20140288389A1 US14/294,304 US201414294304A US2014288389A1 US 20140288389 A1 US20140288389 A1 US 20140288389A1 US 201414294304 A US201414294304 A US 201414294304A US 2014288389 A1 US2014288389 A1 US 2014288389A1
- Authority
- US
- United States
- Prior art keywords
- nerve
- stimulation
- pressure
- retractor
- retraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 48
- 238000012544 monitoring process Methods 0.000 title abstract description 42
- 230000001537 neural effect Effects 0.000 title abstract description 20
- 210000005036 nerve Anatomy 0.000 claims abstract description 193
- 230000007170 pathology Effects 0.000 claims abstract description 27
- 230000000638 stimulation Effects 0.000 claims description 104
- 230000004044 response Effects 0.000 claims description 33
- 230000002232 neuromuscular Effects 0.000 claims description 11
- 238000012545 processing Methods 0.000 claims description 11
- 238000004891 communication Methods 0.000 claims description 9
- 238000013507 mapping Methods 0.000 claims description 7
- 230000000763 evoking effect Effects 0.000 claims description 5
- 230000003190 augmentative effect Effects 0.000 abstract description 9
- 238000012360 testing method Methods 0.000 description 30
- 238000001356 surgical procedure Methods 0.000 description 29
- 230000006870 function Effects 0.000 description 25
- 210000003205 muscle Anatomy 0.000 description 12
- 238000001514 detection method Methods 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 10
- 230000008878 coupling Effects 0.000 description 7
- 238000010168 coupling process Methods 0.000 description 7
- 238000005859 coupling reaction Methods 0.000 description 7
- 230000037361 pathway Effects 0.000 description 7
- 230000004936 stimulating effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 230000036461 convulsion Effects 0.000 description 5
- 210000000278 spinal cord Anatomy 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000036403 neuro physiology Effects 0.000 description 4
- 210000003314 quadriceps muscle Anatomy 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 208000008457 Neurologic Manifestations Diseases 0.000 description 3
- 230000036982 action potential Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000007971 neurological deficit Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000011016 integrity testing Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000000944 nerve tissue Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000007115 recruitment Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 101100521334 Mus musculus Prom1 gene Proteins 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 210000000337 motor cortex Anatomy 0.000 description 1
- 229940035363 muscle relaxants Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000009155 sensory pathway Effects 0.000 description 1
- 210000001032 spinal nerve Anatomy 0.000 description 1
- 210000000273 spinal nerve root Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
- A61B5/395—Details of stimulation, e.g. nerve stimulation to elicit EMG response
-
- A61B5/04001—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/388—Nerve conduction study, e.g. detecting action potential of peripheral nerves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4029—Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4887—Locating particular structures in or on the body
- A61B5/4893—Nerves
Definitions
- the present invention relates to a system and methods generally aimed at surgery. More particularly, the present invention is directed at a system and related methods for performing neurophysiologic assessments with additional pressure monitoring.
- spine surgery may provide great benefit to the patient, often allowing patients to resume activities long since abandoned because of the debilitating pain.
- Spine surgery is not without risk.
- Operating on or near the spine generally means operating in close proximity to delicate neural tissue, such as the spinal cord and nerve roots.
- delicate nerve tissue Often, in order to reach the surgical target site the delicate nerve tissue must be retracted out of the surgical corridor.
- a typical nerve retractor serves to pull or otherwise maintain the nerve outside the area of surgery, thereby protecting the nerve from inadvertent damage or contact by the “active” instrumentation used to perform the actual surgery. While generally advantageous in protecting the nerve, it has been observed that such retraction can cause nerve function to become impaired or otherwise pathologic over time due to the retraction. In certain surgical applications, such as spinal surgery, it is not possible to determine if such retraction is hurting or damaging the retracted nerve until after the surgery (generally referred to as a change in “nerve health” or “nerve status”).
- the present invention is directed at eliminating, or at least reducing the effects of, the above-described problems.
- the present invention includes a system and methods capable of performing a variety of neurophysiologic assessments, and particularly nerve pathology monitoring (via Nerve Retractor mode), by combining neurophysiology monitoring with any of a variety of instruments used in or in preparation for surgery (referred to herein as “surgical accessories”).
- Other assessments performed by the system 10 may include one or more of, but not necessarily limited to, neuromuscular pathway status (Twitch Test), pedicle integrity testing (Screw Test), nerve proximity testing during surgical access (Detection), nerve pathology monitoring (Nerve Retractor), and detection of spontaneous muscle activity (Free Run EMG-which may be conducted alone or in conjunction with any other assessment).
- the nerve pathology monitoring of the present invention may be augmented by equipping a nerve root retractor with one or more pressure sensing technologies and/or providing an additional system or device for assessing or monitoring the pressure being exerted upon a nerve or nerve root before, during and/or after nerve retraction.
- the fundamental method steps for performing the nerve pathology assessments include: (a) stimulating one or more nerves with the surgical accessory (e.g. nerve retractor among others); (b) measuring the response of nerves innervated by the stimulation of step (a); (c) determining a relationship between the surgical accessory and the nerve based upon the response measured in step (b); and (d) communicating this relationship to the surgeon in an easy-to-interpret fashion.
- the surgical accessory e.g. nerve retractor among others
- the step of stimulating one or more nerves may be accomplished by applying any of a variety of suitable stimulation signals to an electrode(s) on the surgical accessory, including voltage and/or current pulses of varying magnitude and/or frequency.
- the stimulating step may be performed at different times depending upon the particular surgical accessory in question. For example, with regard to neural pathology monitoring, stimulation may be performed before, during and/or after retraction of the nerve root, regardless of whether additional pressure sensing features for monitoring the pressure being exerted upon a retracted nerve or nerve root are employed.
- the step of measuring the response of nerves innervated by the stimulation step may be performed in any number of suitable fashions, including but not limited to the use of evoked muscle action potential (EMAP) monitoring techniques (that is, measuring the EMG responses of muscle groups associated with a particular nerve).
- EMG evoked muscle action potential
- the measuring step is preferably accomplished via monitoring or measuring the EMG responses of the muscles innervated by the stimulated nerve(s).
- the step of determining a relationship between the surgical accessory and the nerve based upon the measurement step may be performed in any number of suitable fashions depending upon the manner of measuring the response, and may define the relationship in any of a variety of fashions (based on any number of suitable parameters and/or characteristics).
- the relationship may be, by way of example only, whether the neurophysiologic response of the nerve has changed over time. Such changes may be quickly determined using a hunting algorithm to determine a stimulation threshold current level at various times during the procedure.
- these parameters may be augmented with information regarding the pressure being exerted upon a retracted nerve or nerve root.
- the step of communicating this relationship to the surgeon in an easy-to-interpret fashion may be accomplished in any number of suitable fashions, including but not limited to the use of visual indicia (such as alpha-numeric characters, light-emitting elements, and/or graphics) and audio communications (such as a speaker element).
- visual indicia such as alpha-numeric characters, light-emitting elements, and/or graphics
- audio communications such as a speaker element.
- the determined threshold value may be visually displayed as a simple numerical value on the display.
- color coded graphics may be displayed to indicate the relative safety level indicated by the threshold value.
- the step of communicating the relationship to the user may also include information about the pressure being exerted upon a retracted nerve or nerve root, such as the retraction duration, the extent of retraction, and/or the resulting pressure.
- the nerve pathology monitoring function of the present invention may be augmented with additional pressure sensing capabilities. This may be accomplished by positioning one or more pressure sensors on the nerve retractor and communicatively linking the pressure sensor to pressure mapping software on the control unit or other processor.
- FIG. 1 is a flow chart illustrating the fundamental steps of the neurophysiology-based surgical system according to the present invention
- FIG. 2 is a perspective view of an exemplary system 10 capable of performing neurophysiologic assessments such as for example, detecting pedicle breaches, nerve proximity (detection), nerve pathology, neuromuscular pathway status, and spinal cord health.
- neurophysiologic assessments such as for example, detecting pedicle breaches, nerve proximity (detection), nerve pathology, neuromuscular pathway status, and spinal cord health.
- FIG. 3 is a block diagram of the system 10 shown in FIG. 2 ;
- FIG. 4 is a graph illustrating an exemplary single pulse stimulation signal according to one embodiment of the present invention.
- FIG. 5 is a is a graph illustrating an exemplary multipulse stimulation signal according to one embodiment of the present invention.
- FIG. 6 is a graph illustrating an exemplary EMG response to the stimulus of FIG. 3 or 4 ;
- FIG. 7 is a graph illustrating a plot of peak-to-peak voltage (Vpp) for each given stimulation current level (I Stim ) forming a stimulation current pulse train according to the present invention (otherwise known as a “recruitment curve”);
- FIGS. 8-9 are perspective and side views, respectively, of an exemplary nerve root retractor assembly according to one embodiment of the present invention.
- FIG. 10 is a perspective view of an exemplary nerve root retractor forming part of the assembly of FIGS. 8 and 9 , according to one embodiment of the present invention.
- FIG. 11 is an exemplary screen display illustrating one embodiment of the Nerve Retractor mode for performing neural pathology monitoring according to one embodiment of the present invention
- FIG. 12 is a perspective view of an exemplary nerve root retractor including a pressure sensor according to one embodiment of the present invention.
- FIG. 13 is a perspective view of the system of FIG. 2 adapted to perform additional pressure sensing functions according to one embodiment of the present invention
- FIG. 14 is an exemplary multi-function screen display of the pressure sensing features of the system 10 according to one embodiment of the present invention.
- FIG. 15 is an exemplary full screen display of the 2-dimensional pressure mapping feature according to one embodiment of the present invention.
- FIG. 16 is an exemplary full screen display of the 3-dimensional pressure mapping feature according to one embodiment of the present invention.
- FIG. 17 is an exemplary full screen display of the pressure distribution chart feature according to one embodiment of the present invention.
- FIG. 18 is an exemplary full screen display of the pressure vs. time chart feature according to one embodiment of the present invention.
- FIG. 19 is a perspective view of the system of FIG. 2 adapted to perform additional pressure sensing functions according to a different embodiment of the present invention.
- FIG. 20 is an exemplary screen display illustrating one embodiment of the Nerve Retractor mode for performing neural pathology monitoring augmented by pressure monitoring according to one embodiment of the present invention.
- the present invention is capable of performing a variety of neurophysiologic assessments, and particularly nerve pathology monitoring (via Nerve Retractor mode), by combining neurophysiology monitoring with any of a variety of instruments used in or in preparation for surgery (referred to herein as “surgical accessories”).
- Other assessments performed by the system 10 may include one or more of, but not necessarily limited to, neuromuscular pathway status (Twitch Test), pedicle integrity testing (Screw Test), nerve proximity testing during surgical access (Detection), and detection of spontaneous muscle activity (Free Run EMG—which may be conducted alone or in conjunction with any other mode).
- the nerve pathology monitoring of the present invention may be augmented by equipping a nerve root retractor 29 with one or more pressure sensing technologies and/or providing an additional system or device for assessing or monitoring the pressure being exerted upon a nerve or nerve root before, during and/or after nerve retraction. It is expressly noted that, although described herein largely in terms of use in spinal surgery, the neuromonitoring system 10 and related methods of the present invention are suitable for use in any number of additional surgical procedures where neurological impairment due to nerve retraction is a concern.
- FIG. 1 illustrates the fundamental method steps for performing the nerve pathology assessments (as well as many of the other assessments which may be performed) according to the present invention, namely: (a) stimulating one or more nerves with the surgical accessory (e.g. nerve retactor); (b) measuring the response of nerves innervated by the stimulation of step (a); (c) determining a relationship between the surgical accessory and the nerve based upon the response measured in step (b); and (d) communicating this relationship to the surgeon in an easy-to-interpret fashion.
- the surgical accessory e.g. nerve retactor
- FIGS. 2-3 illustrate, by way of example only, a surgical system 10 provided in accordance with a broad aspect of the present invention.
- the surgical system 10 includes a control unit 12 , a patient module 14 , an EMG harness 16 including 8 pairs of EMG electrodes 18 and a return electrode 22 coupled to the patient module 14 , and a host of surgical accessories 24 capable of being coupled to the patient module 14 via one or more accessory cables 26 .
- the surgical accessories 24 include (by way of example only) a screw test assembly 27 and a nerve root retractor assembly 28 .
- Other surgical accessories not shown here may include, but are not necessarily limited to, a K-wire, a sequential dilation access system (e.g.
- an MEP stimulator (not shown) may also be connected to the system 10 .
- the control unit 12 includes a touch screen display 30 and a base 32 , which collectively contain the essential processing capabilities for controlling the surgical system 10 .
- the patient module 14 is connected to the control unit 12 via a data cable 34 (or optionally via wireless communication), which establishes the electrical connections and communications (digital and/or analog) between the control unit 12 and patient module 14 .
- the main functions of the control unit 12 include receiving user commands via the touch screen display 30 , activating stimulation in the selected mode (e.g. Nerve Retractor), processing signal data according to defined algorithms (described below), displaying received parameters and processed data, and monitoring system status and reporting fault conditions.
- the touch screen display 30 is preferably equipped with a graphical user interface (GUI) capable of communicating information to the user and receiving instructions from the user.
- GUI graphical user interface
- the display 30 and/or base 32 may contain patient module interface circuitry that commands the stimulation sources, receives digitized signals and other information from the patient module 14 , processes the EMG responses to extract characteristic information for each muscle group, and displays the processed data to the operator via the display 30 .
- the step (a) of stimulating one or more target tissues with the surgical accessory 24 is accomplished be coupling one or more surgical accessories 24 equipped with an electrode region(s) to a stimulation source (e.g. the patient module) communicatively linked to the control unit 12 .
- a stimulation source e.g. the patient module
- multiple coupling options are included with the system 10 to accommodate the variety of surgical accessories and functions performed by the system 10 .
- a stimulation handpiece 36 FIG. 1
- the stimulation handpiece 36 may include one or more buttons 38 for selectively initiating stimulation according to the selected function.
- the stimulation handpiece 36 is reusable and sterilizable.
- an electric coupling device such as, by way of example only, stimulation clip 40 and/or stimulation clip 42 ( FIG. 1 ) may be provided to couple surgical accessories 24 (such as for example, a tap member, access probe, tissue retractor assembly, and/or various cannulae) to the system 10 such that stimulation signals may be transmitted through the tool during use.
- the electric coupling device may be used alone or using in conjunction with stimulation handpiece 36 , as is shown.
- Various other connectors may also be employed to couple the surgical accessory to the stimulation source, such as for example, a male/female type socket connection and other commonly know electrical connectors.
- the step (b) of measuring the response of nerves innervated by the stimulation of step (a) may be performed in any number of suitable fashions, including but not limited to the use of evoked muscle action potential (EMAP) monitoring techniques (that is, measuring the EMG responses of muscle groups associated with a particular nerve).
- EMG response monitoring is accomplished via 8 pairs EMG electrodes 18 (placed on the skin over the muscle groups to be monitored), a common electrode 20 providing a ground reference to pre-amplifiers in the patient module 14 , and an anode electrode 22 providing a return path for the stimulation current.
- a preferred EMG electrode for use with the system 10 is a dual surface electrode which is shown and described in detail in the commonly owned and co-pending U.S. patent application Ser. No.
- EMG electrode placement depends on a multitude of factors, including for example, the spinal cord level and particular nerves at risk and user preference, among others. In one embodiment (set forth by way of example only), the preferred EMG configuration is described for Lumbar surgery in Table 1, Thoracolumbar surgery in Table 2, and Cervical surgery in Table 3 below:
- the step (c) of determining a relationship between the surgical accessory and the nerve based upon the response measured in step (b) may be performed in any number of suitable fashions depending upon the manner of measuring the response, and may define the relationship in any of a variety of fashions based on any number of suitable parameters and/or characteristics).
- the step of determining a relationship within the context of a nerve pathology assessment, may involve identifying what stimulation current level is required to evoke a significant muscle response (i.e. the relationship between the surgical accessory (and more specifically the stimulation signal emitted from the surgical accessory) and the nerve may be defined as the stimulation threshold current level, described below).
- a significant EMG response is defined as having a V pp of approximately 100 uV.
- the lowest stimulation signal current, I stim that evokes this threshold voltage (V Thresh ) is called I Thresh .
- Finding I thresh is useful in making neurophysiologic assessments because it provides a relative indication as to the degree of communication between a stimulation signal and nerve tissue. For example, as the degree of electrical communication between a stimulation signal and a nerve decreases, I thresh will increase. Conversely, as the degree of communication between the stimulation signal and a nerve increases, I thresh will decrease.
- the system 10 capitalizes on and enhances the information derived from I thresh by quickly, accurately, and efficiently finding I thresh and comparing the determined value against predetermined safety indicator levels.
- the surgeon may detect early on any problem or potential problem and then act to avoid and/or mitigate the situation.
- an excessively high I thresh or an increase over a previous I thresh measurement during Nerve Retractor mode may indicate a deterioration of nerve root function caused by excessive and/or prolonged retraction.
- a decrease in Ithresh over previous measurements may indicate During Screw Test and Detection modes, a low I thresh value may indicate a breach in the pedicle, or the close proximity of a nerve, respectively.
- the system 10 may employ a variety of suitable algorithms and techniques which are described in detail in the “NeuroVision Applications,” all of which are incorporated by reference below, as if they were set forth herein in their entireties.
- One exemplary threshold hunting algorithm is described hereafter in only brief detail.
- the threshold hunting algorithm utilizes a bracketing method and a bisection method to find I thresh .
- the bracketing method finds a range (bracket) of stimulation currents that must contain I thresh .
- the algorithm directs stimulation to begin at a predetermined current level (based on the selected function). For each subsequent stimulation, the current level is doubled from the previous current level.
- V thresh e.g. 100 uV.
- the initial bracket is successively reduced via the bisection method to a predetermined width. This is accomplished by applying a first bisection stimulation current that bisects (i.e. forms the midpoint of) the initial bracket. If this first bisection stimulation current recruits, the bracket is reduced to the lower half of the initial bracket. If this first bisection stimulation current does not recruit, the bracket is reduced to the upper half of the initial bracket. This process is continued for each successive bracket until I thresh is bracketed by stimulation currents separated by the predetermined width.
- the midpoint of this final bracket may be defined as I thresh ; however, any value falling within the final bracket may be selected as I thresh without departing from the scope of the present invention.
- stimulations may stop after I thresh is determined for the channel possessing the lowest I thresh .
- functions e.g. Screw Tests and Detection
- the hunting algorithm may employ additional methods allowing it to omit certain stimulations, thereby reducing the number of stimulations and time required to obtain an I thresh value on each channel. I thresh is still found using the bracketing and bisection methods described above, however the algorithm will omit stimulations for which the result is predictable from data previously acquired. When a stimulation signal is omitted, the algorithm proceeds as if the stimulation had taken place.
- the algorithm may confirm previously obtained I thresh values (e.g. by stimulation at current levels just below and at/or just above I thresh and determining whether the resulting responses are consistent with the previously acquired I thresh value), rather than initiating stimulations from the beginning each time a function is performed.
- the final step (d) of communicating this relationship to the surgeon in an easy-to-interpret fashion may be accomplished in any number of suitable fashions, including but not limited to the use of visual indicia (such as alpha-numeric characters, light-emitting elements, and/or graphics) and audio communications (such as a speaker element).
- visual indicia such as alpha-numeric characters, light-emitting elements, and/or graphics
- audio communications such as a speaker element
- the determined I thresh value may be visually displayed as a simple numerical value on display 30 .
- color coded graphics may be displayed to indicate the relative safety level indicated by the I thresh (e.g.
- the step of communicating the relationship to the user may also include information about the pressure being exerted upon a retracted nerve or nerve root, such as the retraction duration, the extent of retraction, and/or the resulting pressure.
- the information shown on the display 30 may include at least some of the following components (depending on the active mode) as set forth in Table 1:
- Mode Graphics and/or name to indicate the currently active mode (Twitch Indicator Test, Free-Run EMG, Basic Screw Test, Dynamic Screw Test, Difference Screw Test, Detection, Nerve Retractor).
- Graphics and/or name may also be displayed to indicate the instrument in use, such as the dilator, K-wire, retractor blades, screw test instruments, and associated size information, if applicable, of the cannula, with the numeric size. If no instrument is in use, then no indicator is displayed.
- Stimulation A graphical stimulation indicator depicting the present stimulation Bar status (i.e. on or off and stimulation current level) Sequence Shows the last seven stimulation results and provides for annotation of Bar results.
- EMG EMG waveforms may be optionally displayed on screen along with the waveforms stimulation results.
- Pressure Data regarding pressure being exerted upon a retracted nerve or nerve Indicia root such as the duration of retraction, the extent of retraction, and/or the resulting pressure.
- the various functional modes capable of being performed by system 10 may include, but is not necessarily limited to, the Twitch Test, Free-run EMG, Basic Screw Test, Difference Screw Test, Dynamic Screw Test, MaXcess® Detection, Nerve Retractor, MEP Auto, MEP manual, and SSEP modes, all of which are described only briefly hereafter.
- the Twitch Test mode is designed to assess the neuromuscular pathway via the so-called “train-of-four test” test to ensure the neuromuscular pathway is free from muscle relaxants prior to performing neurophysiology-based testing, such as bone integrity (e.g. pedicle) testing, nerve detection, and nerve retraction. This is described in greater detail within Int'l Patent App. No.
- PCT/US2005/036089 entitled “System and Methods for Assessing the Neuromuscular Pathway Prior to Nerve Testing,” filed Oct. 7, 2005, the entire contents of which is hereby incorporated by reference as if set forth fully herein.
- the Basic Screw Test, Difference Screw Test, and Dynamic Screw Test modes are designed to assess the integrity of bone (e.g. pedicle) during all aspects of pilot hole formation (e.g., via an awl), pilot hole preparation (e.g. via a tap), and screw introduction (during and after). These modes are described in greater detail in Int'l Patent App. No. PCT/US02/35047 entitled “System and Methods for Performing Percutaneous Pedicle Integrity Assessments,” filed on Oct.
- the MaXcess® Detection mode is designed to detect the presence of nerves during the use of the various surgical access instruments of the neuromonitoring system 10 , including the k-wire 62 , dilator 64 , cannula 66 , retractor assembly 70 . This mode is described in greater detail within Int'l Patent App. No PCT/US02/22247, entitled “System and Methods for Determining Nerve Proximity, Direction, and Pathology During Surgery,” filed on Jul.
- the MEP Auto and MEP Manual modes are designed to test the motor pathway to detect potential damage to the spinal cord by stimulating the motor cortex in the brain and recording the resulting EMG response of various muscles in the upper and lower extremities.
- the SSEP function is designed to test the sensory pathway to detect potential damage to the spinal cord by stimulating peripheral nerves inferior to the target spinal level and recording the action potential from sensors superior to the spinal level.
- the MEP Auto, MEP manual, and SSEP modes are described in greater detail within Int'l Patent App. No. PCT/US2006/003966, entitled “System and Methods for Performing Neurophysiologic Assessments During Spine Surgery,” filed on Feb.
- the Nerve Retractor mode is designed to assess the health or pathology of a nerve before, during, and after retraction of the nerve during a surgical procedure. This mode is described in greater detail within Int'l Patent App. No. PCT/US02/30617, entitled “System and Methods for Performing Surgical Procedures and Assessments,” filed on Sep. 25, 2002, the entire contents of which is hereby incorporated by reference as if set forth fully herein.
- Nerve pathology monitoring as it may be performed by the system 10 during Nerve Retractor mode is described hereafter in more detail.
- the system 10 preferably accomplishes neural pathology monitoring via the Nerve Retractor mode, specifically by determining a baseline stimulation threshold (again, stimulation threshold is the value I thresh ) with direct contact between the nerve retractor 29 and the nerve, prior to retraction. Subsequent stimulation thresholds are determined during retraction and they are compared to the baseline threshold. Significant changes in the stimulation threshold may indicate potential trauma to the nerve caused by the retraction and are displayed to the user on the display 30 . An increase in I thresh over time is an indication that the nerve function is deteriorating.
- I thresh may preferably be determined for each channel according to the multi-channel hunting algorithm described above.
- the nerve root retractor assembly 28 shown in a preferred embodiment in FIGS. 8-10 , comprises the stimulation handpiece 36 employed with a selectively removable nerve root retractor 29 .
- the nerve root retractor 29 has a generally angled orientation relative to the longitudinal axis of the stimulation handpiece 36 .
- the distal end 44 is generally curved and includes an arcuate nerve engagement surface 46 equipped with, by way of example only, at least one stimulation electrode 48 .
- the nerve root retractor 29 is preferably removable from the stimulation handpiece 36 .
- the stimulation handpiece 36 includes a detachable cap member 50 .
- Threads 52 are provided on the proximal end of the nerve root retractor 29 to allow a threaded coupling engagement between the stimulation handpiece 36 and the nerve root retractor 29 .
- electrical contacts 54 on the nerve root retractor 29 become electrically coupled to the stimulation handpiece 36 such that, upon activation of one or more of the buttons 38 a stimulation current signal will be transmitted from the control unit 12 and/or patient module 14 and delivered to the stimulation electrode(s) 48 on the nerve root retractor 29 for the purpose of performing neural pathology monitoring according to the present invention.
- the nerve root retractor 29 is preferably disposable and, as described above, the stimulation handpiece 36 is preferably reusable and sterilizable.
- nerve retractor 29 is shown primarily in use with the stimulation handpiece 36 to form nerve retractor assembly 28 , nerve retractor 29 may be used with any suitable handle and/or may include a fixed handle. When nerve retractor 29 is used without stimulation handpiece 36 it may be coupled to the system 10 via one of the electric coupling devices 40 , 42 , a male/female type electrical coupler, or any other form of electric coupling.
- the nerve root retractor 29 is introduced into or near a surgical target site in order to hook and retract a given nerve out of the way.
- the nerve root may be stimulated (monopolar or bipolar) before, during, and/or after retraction in order to assess the degree to which such retraction impairs or otherwise degrades nerve function over time.
- the user may operate one or more buttons 38 of the stimulation handpiece 36 to selectively transmit a stimulation current signal, according to the algorithm described above, from the patient module 14 to the electrode(s) 48 on the engagement surface 46 of the nerve root retractor 29 .
- the system 10 can assess whether (and the degree to which) such retraction impairs or adversely affects nerve function over time. With this information, a user may wish to periodically release the nerve root from retraction to allow nerve function to recover, thereby preventing or minimizing the risk of long-term or irreversible nerve impairment. Similarly, an unhealthy nerve may be monitored in the same manner to determine if nerve function improves due to a particular procedure, such as spinal nerve decompression surgery.
- the nerve retraction monitoring feature of the present invention is best viewed with regard to FIG. 11 .
- the screen display for the Nerve Retractor mode may include any of a variety of indicia capable of communicating parameters associated with the nerve retraction monitoring feature of the present invention to a surgeon, including but not limited to, channel windows containing one or more of the channel number, myotome name, spinal level, baseline I thresh , previous I thresh , current I thresh , and the associated waveform, and various selection tabs for one or more of starting baseline stimulation, starting retraction stimulation, stopping stimulation, activating free-run EMG monitoring and adjusting the sensitivity of the free-run EMG, noting the retraction site, mode selection, annotating results, and remote messaging.
- the nerve pathology assessments (Nerve Retractor mode) conducted by the system 10 may be further augmented via the use of any number of pressure sensing technologies working in addition to the stimulation based nerve monitoring described above and throughout this disclosure.
- the pressure sensing features contemplated herein offer added safety and qualitative assessment features by providing the ability to monitor how much pressure is being applied to a particular nerve during nerve root retraction. This pressure may be a function of, among other factors, the degree of retraction (that is, distance the nerve is moved during retraction) and the duration of retraction. In any case, the pressure resulting on a nerve during retraction—if too high in magnitude and/or too long in duration—may result in neurologic deficit of varying degrees.
- a user may selectively reduce the degree of retraction (such as by moving the retractor assembly 28 and nerve closer to the “natural” position of the nerve) and/or periodically releasing the nerve to avoid and/or minimize any resulting neurologic deficit due to retraction.
- the pressure sensing technologies may include any number of commercially available and/or publicly known pressure sensing technologies, and/or those later developed.
- the commercially available and/or publicly known pressure sensing technologies include, but are not necessarily limited to, the piezoelectric-based pressure sensing technique shown and described in U.S. Pat. No. 5,769,781 to James Chumbles, the capacitive-based pressure mapping system shown and described in U.S. Pat. No. 5,010,772 to Bourland et. al., the strain gauge-based pressure sensing technology shown and described in U.S. Pat. No. 4,784,150 to Voorhies et. al., the pressure sensitive ink-based technique shown and described in U.S. Pat. No. 5,989,700 to Krivopal, and that shown and described in U.S. Pat. No. 6,272,936 to Oreper et. al.
- Augmenting the nerve pathology monitoring with pressure sensing capabilities may be accomplished in any number of suitable manners, including but not limited to equipping the nerve retractor assembly 28 (and more specifically, one or more of the nerve root retractor 29 , the stimulation handpiece 36 , the distal end 44 , and the nerve engagement surface 46 ) with one or more pressure sensing technologies.
- this may be done by equipping the nerve engagement surface 46 with a pressure sensor 56 .
- the pressure sensor 56 illustrated in FIG. 12 is a capacitive foam grid (comprising any number of suitable grid units) adhered to nerve engagement surface 46 of nerve retractor 29 .
- pressure sensor 56 is shown herein having a small number of relatively large grid units, this is done for illustrative purposes. It will be readily understood by those skilled in the art that that any number of grid units and unit sizes may be utilized, and sensor 56 preferably comprises a large number of relatively small grid units to increase precision.
- a data cable (not shown) may be run along the nerve retractor 29 , and is preferably integrated within the interior of nerve retractor 29 , and from there may be connected to the processing unit via cable 58 .
- wireless communication may be used to link the pressure sensor and processing unit.
- the processor may be control unit 12 or an additional dedicated processor may be employed for pressure sensing features.
- pressure applied to the capacitive foam grid induces voltage responses corresponding to the affected grid units.
- the voltage responses are relayed to the processor which translates the response into one or more of numerical and/or graphical (e.g. color) indicia relating to pressure, which may be displayed to the surgeon.
- a separate system or device may be employed for assessing or monitoring the pressure being exerted upon a nerve or nerve root before, during and/or after nerve retraction.
- a separate system may supplant (that is, take the place of) and/or augment (that is, serve in along with) the nerve root retractor 29 equipped with pressure sensing capabilities described above.
- the pressure sensing features of the system 10 are controlled via a separate processing unit 60 while the EMG based nerve monitoring features are controlled via control unit 12 (as described throughout the description).
- Processing unit 60 is preferably a personal workstation or laptop computer (by way of example only) running pressure sensing software designed to interface with the pressure sensor 56 and display pressure data to the user on the processor screen 62 .
- One such software program is the X3 Series software distributed by XSENSORTM Technology Corporation, Calgary Canada.
- processing unit 60 is preferably arranged near the control unit 12 such that the surgeon may view nerve pathology data from the display 30 and pressure data from screen 62 at the same time.
- pressure applied to the retracted nerve may be a function of, among other factors, the degree of retraction (that is, distance the nerve is moved during retraction) and the duration of retraction, either of which may result in neurologic deficit of varying degrees.
- FIG. 14 illustrates by way of example, a multi-function screen view of the pressure sensing software.
- the multi-function screen may include (by way of example only) a 2-dimensional (2-D) grid map 64 , a 3-dimensional (3-D) grid map 66 , and a pressure distribution chart 68 , and a pressure vs.
- the tool bar 74 and legend 72 may be found on all screen views of the pressure mapping software.
- the tool bar 74 allows the user to select between different view screens, among other functions (such as for example, selecting the desired sensor range and precision).
- the legend 74 indicates the numerical pressure value associated with a specific color (e.g. in one example red indicates the highest pressure of the selected range, 15.0 PSI in FIG. 14 ).
- FIGS. 15-18 illustrate exemplary embodiments of the full screen displays.
- FIG. 15 is a full screen display of the 2-D grid map 64 , wherein various colors are used (according to the legend 72 ) to indicate the amount of pressure measured for each grid unit on the sensor 56 .
- a reference marker 76 is included which corresponds to a specific corner of the pressure sensor 56 , to help orient the viewer.
- FIG. 16 illustrates the full screen display of the 3-D grid map, wherein various colors (according to the legend 72 ) are again used to indicate the amount of pressure measured on the grid units of sensor 56 .
- FIG. 15 is a full screen display of the 2-D grid map 64 , wherein various colors are used (according to the legend 72 ) to indicate the amount of pressure measured for each grid unit on the sensor 56 .
- a reference marker 76 is included which corresponds to a specific corner of the pressure sensor 56 , to help orient the viewer.
- FIG. 16 illustrates the full screen display of the 3-D grid map, wherein various colors
- FIG. 17 illustrates the full screen display of the pressure distribution graph 68 , wherein the vertical axis indicates the percentage of grid units at the given moment which are under a measured pressure falling within the pressure intervals on the horizontal axis.
- FIG. 18 shows the full screen display of a PvT graph, wherein the maximum pressure measured on sensor 56 is charted against the retraction time.
- the surgeon may keep be kept aware to the extent which pressure is applied to a nerve throughout retraction, and also the length of time which a nerve is retracted.
- the 2-D and 3-D maps 64 , 66 also allow the surgeon to quickly assess not only the extent and duration of the pressure, but also the position, orientation, and center mass of the nerve retractor 29 on the nerve.
- the processor 60 may preferably be viewed in real time, however, the processor 60 may also save the data for the entire procedure and the surgeon may go back and view any data from the same procedure at any time.
- the pressure sensing features of the system 10 are controlled via the control unit 12 and the pressure features may be fully integrated with the Nerve Retractor mode described above.
- both the pressure sensor 56 and the stimulation electrode 48 are communicatively linked to the patient module 14 and pressure data is preferably viewed from within the Nerve Retractor screen display (discussed above with reference to FIG. 11 ).
- An embodiment of the Nerve Retractor screen display when system 10 is augmented with pressure sensing capabilities according to this embodiment is illustrated by way of example only in FIG. 20 .
- the screen display includes, among its other features, a pressure selection tab 78 for initiating pressure monitoring (preferably at the same time nerve retraction) begins, a maximum pressure readout 80 , and a timer readout 82 . Selecting the pressure selection tab 78 using the GUI activates the pressure sensor 56 and starts the timer. The running time is displayed to the user in the timer readout 82 . The maximum pressure measured on the sensor 56 is displayed with constant real time updating.
- any of a number of various features such as the 2-D and 3-D grid maps, pressure distribution, and pressure vs. time graph may also be generated and displayed in this embodiment.
- Pressure data measured by the system 10 is recorded and saved such that it may be accessed again if necessary. Pressure data may also be included in procedure reports generated by the system 10 such that an accurate record is easily obtained.
- monitoring retraction pressure may be useful for any number of different body tissues which must be retracted out of the way during surgery.
- it may be extremely beneficial to monitor retraction pressure on the larynx and/or esophagus which must be retracted during anterior cervical procedure.
- the data may be transmitted (along with the nerve pathology and other neurophysiologic assessment data) to one or more remote locations and viewable by authorized persons. This may be accomplished by any number of data transmission methods.
- the data may be transmitted to a remote user via remote monitoring software such as that described in detail in the commonly owned and co-pending U.S. patent application Ser. No. 11/418,589, entitled “System and Methods for Performing and Monitoring Neurophysiologic Assessments,” filed on May 5, 2006, the entire contents of which are incorporated by reference herein as if set forth in its entirety.
- the present invention may be implemented using any combination of computer programming software, firmware or hardware.
- the computer programming code (whether software or firmware) according to the invention will typically be stored in one or more machine readable storage mediums such as fixed (hard) drives, diskettes, optical disks, magnetic tape, semiconductor memories such as ROMs, PROMs, etc., thereby making an article of manufacture in accordance with the invention.
- the article of manufacture containing the computer programming code is used by either executing the code directly from the storage device, by copying the code from the storage device into another storage device such as a hard disk, RAM, etc. or by transmitting the code on a network for remote execution.
- a hard disk such as a hard disk, RAM, etc.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Physiology (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
Description
- This application is a continuation of U.S. application Ser. No. 11/490,717 filed Jul. 20, 2006, now U.S. Pat. No. 8,740,783, which claims the benefit of priority from commonly owned and co-pending U.S. Provisional Application No. 60/701,305 entitled “System and Methods for Determining Nerve Proximity, Nerve Direction, and Nerve Pathology During Surgery” filed Jul. 20, 2005, the entire contents of which are expressly incorporated by reference into this disclosure as if set forth herein in its entirety.
- I. Field of the Invention
- The present invention relates to a system and methods generally aimed at surgery. More particularly, the present invention is directed at a system and related methods for performing neurophysiologic assessments with additional pressure monitoring.
- II. Description of Related Art
- It has been estimated that somewhere between 50 and 70 million people suffer from chronic back pain in the United States. In most cases, conservative therapies, including, for example, bed rest and physical therapy will succeed in alleviating or at least significantly reducing the back pain. Still, a significant number of patients are unaided by conservative therapies alone and undergo spinal surgery before finding relief. The rate at which caregivers and patients opt for surgery also continues to grow as medical technology advances and surgical options increase. In all, approximately 750,000 spine surgeries are performed per year in the United States alone.
- When necessary, spine surgery may provide great benefit to the patient, often allowing patients to resume activities long since abandoned because of the debilitating pain. Spine surgery, however, is not without risk. Operating on or near the spine generally means operating in close proximity to delicate neural tissue, such as the spinal cord and nerve roots. Often, in order to reach the surgical target site the delicate nerve tissue must be retracted out of the surgical corridor. A typical nerve retractor serves to pull or otherwise maintain the nerve outside the area of surgery, thereby protecting the nerve from inadvertent damage or contact by the “active” instrumentation used to perform the actual surgery. While generally advantageous in protecting the nerve, it has been observed that such retraction can cause nerve function to become impaired or otherwise pathologic over time due to the retraction. In certain surgical applications, such as spinal surgery, it is not possible to determine if such retraction is hurting or damaging the retracted nerve until after the surgery (generally referred to as a change in “nerve health” or “nerve status”).
- The present invention is directed at eliminating, or at least reducing the effects of, the above-described problems.
- The present invention includes a system and methods capable of performing a variety of neurophysiologic assessments, and particularly nerve pathology monitoring (via Nerve Retractor mode), by combining neurophysiology monitoring with any of a variety of instruments used in or in preparation for surgery (referred to herein as “surgical accessories”). Other assessments performed by the
system 10 may include one or more of, but not necessarily limited to, neuromuscular pathway status (Twitch Test), pedicle integrity testing (Screw Test), nerve proximity testing during surgical access (Detection), nerve pathology monitoring (Nerve Retractor), and detection of spontaneous muscle activity (Free Run EMG-which may be conducted alone or in conjunction with any other assessment). The nerve pathology monitoring of the present invention may be augmented by equipping a nerve root retractor with one or more pressure sensing technologies and/or providing an additional system or device for assessing or monitoring the pressure being exerted upon a nerve or nerve root before, during and/or after nerve retraction. - The fundamental method steps for performing the nerve pathology assessments (as well as many of the other assessments which may be performed) according to the present invention include: (a) stimulating one or more nerves with the surgical accessory (e.g. nerve retractor among others); (b) measuring the response of nerves innervated by the stimulation of step (a); (c) determining a relationship between the surgical accessory and the nerve based upon the response measured in step (b); and (d) communicating this relationship to the surgeon in an easy-to-interpret fashion.
- The step of stimulating one or more nerves may be accomplished by applying any of a variety of suitable stimulation signals to an electrode(s) on the surgical accessory, including voltage and/or current pulses of varying magnitude and/or frequency. The stimulating step may be performed at different times depending upon the particular surgical accessory in question. For example, with regard to neural pathology monitoring, stimulation may be performed before, during and/or after retraction of the nerve root, regardless of whether additional pressure sensing features for monitoring the pressure being exerted upon a retracted nerve or nerve root are employed.
- The step of measuring the response of nerves innervated by the stimulation step may be performed in any number of suitable fashions, including but not limited to the use of evoked muscle action potential (EMAP) monitoring techniques (that is, measuring the EMG responses of muscle groups associated with a particular nerve). According to one aspect of the present invention, the measuring step is preferably accomplished via monitoring or measuring the EMG responses of the muscles innervated by the stimulated nerve(s).
- The step of determining a relationship between the surgical accessory and the nerve based upon the measurement step may be performed in any number of suitable fashions depending upon the manner of measuring the response, and may define the relationship in any of a variety of fashions (based on any number of suitable parameters and/or characteristics). By way of example, for neural pathology assessments according to the present invention, the relationship may be, by way of example only, whether the neurophysiologic response of the nerve has changed over time. Such changes may be quickly determined using a hunting algorithm to determine a stimulation threshold current level at various times during the procedure. According to one embodiment, these parameters may be augmented with information regarding the pressure being exerted upon a retracted nerve or nerve root.
- The step of communicating this relationship to the surgeon in an easy-to-interpret fashion may be accomplished in any number of suitable fashions, including but not limited to the use of visual indicia (such as alpha-numeric characters, light-emitting elements, and/or graphics) and audio communications (such as a speaker element). By way of example, for nerve pathology monitoring, the determined threshold value may be visually displayed as a simple numerical value on the display. In addition, color coded graphics may be displayed to indicate the relative safety level indicated by the threshold value. When pressure sensing capabilities are added to the nerve root retractor according to one aspect of the present invention, the step of communicating the relationship to the user may also include information about the pressure being exerted upon a retracted nerve or nerve root, such as the retraction duration, the extent of retraction, and/or the resulting pressure.
- The nerve pathology monitoring function of the present invention may be augmented with additional pressure sensing capabilities. This may be accomplished by positioning one or more pressure sensors on the nerve retractor and communicatively linking the pressure sensor to pressure mapping software on the control unit or other processor.
- Many advantages of the present invention will be apparent to those skilled in the art with a reading of this specification in conjunction with the attached drawings, wherein like reference numerals are applied to like elements and wherein:
-
FIG. 1 is a flow chart illustrating the fundamental steps of the neurophysiology-based surgical system according to the present invention; -
FIG. 2 is a perspective view of anexemplary system 10 capable of performing neurophysiologic assessments such as for example, detecting pedicle breaches, nerve proximity (detection), nerve pathology, neuromuscular pathway status, and spinal cord health. -
FIG. 3 is a block diagram of thesystem 10 shown inFIG. 2 ; -
FIG. 4 is a graph illustrating an exemplary single pulse stimulation signal according to one embodiment of the present invention; -
FIG. 5 is a is a graph illustrating an exemplary multipulse stimulation signal according to one embodiment of the present invention; -
FIG. 6 is a graph illustrating an exemplary EMG response to the stimulus ofFIG. 3 or 4; -
FIG. 7 is a graph illustrating a plot of peak-to-peak voltage (Vpp) for each given stimulation current level (IStim) forming a stimulation current pulse train according to the present invention (otherwise known as a “recruitment curve”); -
FIGS. 8-9 are perspective and side views, respectively, of an exemplary nerve root retractor assembly according to one embodiment of the present invention; -
FIG. 10 is a perspective view of an exemplary nerve root retractor forming part of the assembly ofFIGS. 8 and 9 , according to one embodiment of the present invention; -
FIG. 11 is an exemplary screen display illustrating one embodiment of the Nerve Retractor mode for performing neural pathology monitoring according to one embodiment of the present invention; -
FIG. 12 is a perspective view of an exemplary nerve root retractor including a pressure sensor according to one embodiment of the present invention; -
FIG. 13 is a perspective view of the system ofFIG. 2 adapted to perform additional pressure sensing functions according to one embodiment of the present invention; -
FIG. 14 is an exemplary multi-function screen display of the pressure sensing features of thesystem 10 according to one embodiment of the present invention; -
FIG. 15 is an exemplary full screen display of the 2-dimensional pressure mapping feature according to one embodiment of the present invention; -
FIG. 16 is an exemplary full screen display of the 3-dimensional pressure mapping feature according to one embodiment of the present invention; -
FIG. 17 is an exemplary full screen display of the pressure distribution chart feature according to one embodiment of the present invention; -
FIG. 18 is an exemplary full screen display of the pressure vs. time chart feature according to one embodiment of the present invention; -
FIG. 19 is a perspective view of the system ofFIG. 2 adapted to perform additional pressure sensing functions according to a different embodiment of the present invention; and -
FIG. 20 is an exemplary screen display illustrating one embodiment of the Nerve Retractor mode for performing neural pathology monitoring augmented by pressure monitoring according to one embodiment of the present invention. - Illustrative embodiments of the invention are described below. In the interest of clarity, not all features of an actual implementation are described in this specification. It will of course be appreciated that in the development of any such actual embodiment, numerous implementation-specific decisions must be made to achieve the developers' specific goals, such as compliance with system-related and business-related constraints, which will vary from one implementation to another. Moreover, it will be appreciated that such a development effort might be complex and time-consuming, but would nevertheless be a routine undertaking for those of ordinary skill in the art having the benefit of this disclosure. The systems disclosed herein boast a variety of inventive features and components that warrant patent protection, both individually and in combination.
- The present invention is capable of performing a variety of neurophysiologic assessments, and particularly nerve pathology monitoring (via Nerve Retractor mode), by combining neurophysiology monitoring with any of a variety of instruments used in or in preparation for surgery (referred to herein as “surgical accessories”). Other assessments performed by the
system 10 may include one or more of, but not necessarily limited to, neuromuscular pathway status (Twitch Test), pedicle integrity testing (Screw Test), nerve proximity testing during surgical access (Detection), and detection of spontaneous muscle activity (Free Run EMG—which may be conducted alone or in conjunction with any other mode). As will be described in greater detail below, the nerve pathology monitoring of the present invention may be augmented by equipping anerve root retractor 29 with one or more pressure sensing technologies and/or providing an additional system or device for assessing or monitoring the pressure being exerted upon a nerve or nerve root before, during and/or after nerve retraction. It is expressly noted that, although described herein largely in terms of use in spinal surgery, theneuromonitoring system 10 and related methods of the present invention are suitable for use in any number of additional surgical procedures where neurological impairment due to nerve retraction is a concern. -
FIG. 1 illustrates the fundamental method steps for performing the nerve pathology assessments (as well as many of the other assessments which may be performed) according to the present invention, namely: (a) stimulating one or more nerves with the surgical accessory (e.g. nerve retactor); (b) measuring the response of nerves innervated by the stimulation of step (a); (c) determining a relationship between the surgical accessory and the nerve based upon the response measured in step (b); and (d) communicating this relationship to the surgeon in an easy-to-interpret fashion. -
FIGS. 2-3 illustrate, by way of example only, asurgical system 10 provided in accordance with a broad aspect of the present invention. Thesurgical system 10 includes acontrol unit 12, apatient module 14, anEMG harness 16 including 8 pairs ofEMG electrodes 18 and areturn electrode 22 coupled to thepatient module 14, and a host ofsurgical accessories 24 capable of being coupled to thepatient module 14 via one or moreaccessory cables 26. In the embodiment shown, thesurgical accessories 24 include (by way of example only) ascrew test assembly 27 and a nerveroot retractor assembly 28. Other surgical accessories not shown here may include, but are not necessarily limited to, a K-wire, a sequential dilation access system (e.g. dilating and working cannulae), taps, pedicle access probes, tissue retractor assemblies, and surface electrodes etc. . . . Additional components, such as for example an MEP stimulator (not shown) may also be connected to thesystem 10. - The
control unit 12 includes atouch screen display 30 and abase 32, which collectively contain the essential processing capabilities for controlling thesurgical system 10. Thepatient module 14 is connected to thecontrol unit 12 via a data cable 34 (or optionally via wireless communication), which establishes the electrical connections and communications (digital and/or analog) between thecontrol unit 12 andpatient module 14. The main functions of thecontrol unit 12 include receiving user commands via thetouch screen display 30, activating stimulation in the selected mode (e.g. Nerve Retractor), processing signal data according to defined algorithms (described below), displaying received parameters and processed data, and monitoring system status and reporting fault conditions. Thetouch screen display 30 is preferably equipped with a graphical user interface (GUI) capable of communicating information to the user and receiving instructions from the user. Thedisplay 30 and/orbase 32 may contain patient module interface circuitry that commands the stimulation sources, receives digitized signals and other information from thepatient module 14, processes the EMG responses to extract characteristic information for each muscle group, and displays the processed data to the operator via thedisplay 30. - The step (a) of stimulating one or more target tissues with the
surgical accessory 24 is accomplished be coupling one or moresurgical accessories 24 equipped with an electrode region(s) to a stimulation source (e.g. the patient module) communicatively linked to thecontrol unit 12. Preferably, multiple coupling options are included with thesystem 10 to accommodate the variety of surgical accessories and functions performed by thesystem 10. By way of example only, a stimulation handpiece 36 (FIG. 1 ) may connect to thepatient module 14 via anaccessory cable 26 at one end, and couple a surgical accessory 24 (e.g. nerve retractor 29—thereby formingnerve retractor assembly 28; or a pedicle probe member—thereby forming screw test assembly 27) at the other end. Thestimulation handpiece 36 may include one ormore buttons 38 for selectively initiating stimulation according to the selected function. In a preferred embodiment thestimulation handpiece 36 is reusable and sterilizable. By way of further example only, an electric coupling device such as, by way of example only,stimulation clip 40 and/or stimulation clip 42 (FIG. 1 ) may be provided to couple surgical accessories 24 (such as for example, a tap member, access probe, tissue retractor assembly, and/or various cannulae) to thesystem 10 such that stimulation signals may be transmitted through the tool during use. The electric coupling device may be used alone or using in conjunction withstimulation handpiece 36, as is shown. Various other connectors may also be employed to couple the surgical accessory to the stimulation source, such as for example, a male/female type socket connection and other commonly know electrical connectors. - The step (b) of measuring the response of nerves innervated by the stimulation of step (a) may be performed in any number of suitable fashions, including but not limited to the use of evoked muscle action potential (EMAP) monitoring techniques (that is, measuring the EMG responses of muscle groups associated with a particular nerve). In a preferred embodiment, EMG response monitoring is accomplished via 8 pairs EMG electrodes 18 (placed on the skin over the muscle groups to be monitored), a
common electrode 20 providing a ground reference to pre-amplifiers in thepatient module 14, and ananode electrode 22 providing a return path for the stimulation current. A preferred EMG electrode for use with thesystem 10 is a dual surface electrode which is shown and described in detail in the commonly owned and co-pending U.S. patent application Ser. No. 11,048,404, entitled “Improved Electrode System and Related Methods,” filed on Jan. 31, 2005, which is expressly incorporated by reference into this disclosure as if set forth in its entirety herein. It should be appreciated however, that any of a variety of known electrodes can be employed, including but not limited to surface pad electrodes and needle electrodes. It should also be appreciated that EMG electrode placement depends on a multitude of factors, including for example, the spinal cord level and particular nerves at risk and user preference, among others. In one embodiment (set forth by way of example only), the preferred EMG configuration is described for Lumbar surgery in Table 1, Thoracolumbar surgery in Table 2, and Cervical surgery in Table 3 below: -
TABLE 1 Lumbar Spinal Color Channel Myotome Nerve Level Red Right 1 Right Vastus Medialis Femoral L2, L3, L4 Orange Right 2 Right Tibialis Anterior Common L4, L5 Peroneal Yellow Right 3 Right Biceps Femoris Sciatic L5, S1, S2 Green Right 4 Right Medial Gastroc. Post Tibial S1, S2 Blue Left 1 Left Vastus Medialis Femoral L2, L3, L4 Violet Left 2 Left Tibialis Anterior Common L4, L5 Peroneal Gray Left 3 Left Biceps Femoris Sciatic L5, S1, S2 White Left 4 Left Medial Gastroc. Post Tibial S1, S2 -
TABLE 2 Thoracolumbar Spinal Color Channel Myotome Nerve Level Red Right 1 Right Abductor Median C6, C7, C8, T1 Pollicis Brevis Orange Right 2 Right Vastus Medialis Femoral L2, L3, L4 Yellow Right 3 Right Tibialis Anterior Common L4, L5 Peroneal Green Right 4 Right Abductor Hallucis Tibial L4, L5, S1 Blue Left 1 Left Abductor Median C6, C7, C8, T1 Pollicis Brevis Violet Left 2 Left Vastus Medialis Femoral L2, L3, L4 Gray Left 3 Left Tibialis Anterior Common L4, L5 Peroneal White Left 4 Left Abductor Hallucis Tibial L4, L5, S1 -
TABLE 3 Cervical Spinal Color Channel Myotome Nerve Level Red Right 1 Right Deltoid Axilliary C5, C6 Orange Right 2 Right Flexor Median C6, C7, C8 Carpi Radialis Yellow Right 3 Right Abductor Median C6, C7, C8, T1 Pollicis Brevis Green Right 4 Right Abductor Hallucis Tibial L4, L5, S1 Blue Left 1 Left Deltoid Axillary C5, C6 Violet Left 2 Left Flexor Median C6, C7, C8 Carpi Radialis Gray Left 3 Left Abductor Median C6, C7, C8, T1 Pollicis Brevis White Left 4 Left Abductor Hallucis Tibial L4, L5, S1 - The step (c) of determining a relationship between the surgical accessory and the nerve based upon the response measured in step (b) may be performed in any number of suitable fashions depending upon the manner of measuring the response, and may define the relationship in any of a variety of fashions based on any number of suitable parameters and/or characteristics). By way of example only, the step of determining a relationship, within the context of a nerve pathology assessment, may involve identifying what stimulation current level is required to evoke a significant muscle response (i.e. the relationship between the surgical accessory (and more specifically the stimulation signal emitted from the surgical accessory) and the nerve may be defined as the stimulation threshold current level, described below).
- A basic premise underlying the methods employed by the
system 10 for much of the neurophysiologic monitoring conducted is that neurons and nerves have characteristic threshold current levels (IThresh) at which they will depolarize, resulting in detectable muscle activity. Below this threshold current, stimulation signals, such as the single pulse signal shown by way of example only inFIG. 4 and the multi-pulse signal shown by way of example only inFIG. 5 , will not evoke a significant EMG response. Each EMG response can be characterized by a peak-to-peak voltage of Vpp=Vmax−Vmin, shown inFIG. 6 . Once the stimulation threshold (IThresh) is reached, the evoked response is reproducible and increases with increasing stimulation until saturation is reached as shown inFIG. 7 . This is known as a “recruitment curve.” In one embodiment, a significant EMG response is defined as having a Vpp of approximately 100 uV. The lowest stimulation signal current, Istim that evokes this threshold voltage (VThresh) is called IThresh. Finding Ithresh is useful in making neurophysiologic assessments because it provides a relative indication as to the degree of communication between a stimulation signal and nerve tissue. For example, as the degree of electrical communication between a stimulation signal and a nerve decreases, Ithresh will increase. Conversely, as the degree of communication between the stimulation signal and a nerve increases, Ithresh will decrease. - The
system 10 capitalizes on and enhances the information derived from Ithresh by quickly, accurately, and efficiently finding Ithresh and comparing the determined value against predetermined safety indicator levels. Armed with the useful information conveyed by thesystem 10, the surgeon may detect early on any problem or potential problem and then act to avoid and/or mitigate the situation. By way of general example only, an excessively high Ithresh or an increase over a previous Ithresh measurement during Nerve Retractor mode may indicate a deterioration of nerve root function caused by excessive and/or prolonged retraction. On the opposite hand, a decrease in Ithresh over previous measurements may indicate During Screw Test and Detection modes, a low Ithresh value may indicate a breach in the pedicle, or the close proximity of a nerve, respectively. - To quickly determine Ithresh, the
system 10 may employ a variety of suitable algorithms and techniques which are described in detail in the “NeuroVision Applications,” all of which are incorporated by reference below, as if they were set forth herein in their entireties. One exemplary threshold hunting algorithm is described hereafter in only brief detail. The threshold hunting algorithm utilizes a bracketing method and a bisection method to find Ithresh. The bracketing method finds a range (bracket) of stimulation currents that must contain Ithresh. To accomplish this, the algorithm directs stimulation to begin at a predetermined current level (based on the selected function). For each subsequent stimulation, the current level is doubled from the previous current level. This doubling continues until a until a stimulation current recruits, that is, results in an EMG response with a Vpp greater or equal to Vthresh (e.g. 100 uV). This first stimulation current to recruit, together with the last stimulation current to have not recruited, forms the initial bracket. If the stimulation current threshold, Ithresh, of a channel exceeds a maximum stimulation current, that threshold is considered out of range. - After the bracket containing the threshold current Ithresh has been determined, the initial bracket is successively reduced via the bisection method to a predetermined width. This is accomplished by applying a first bisection stimulation current that bisects (i.e. forms the midpoint of) the initial bracket. If this first bisection stimulation current recruits, the bracket is reduced to the lower half of the initial bracket. If this first bisection stimulation current does not recruit, the bracket is reduced to the upper half of the initial bracket. This process is continued for each successive bracket until Ithresh is bracketed by stimulation currents separated by the predetermined width. In one embodiment, the midpoint of this final bracket may be defined as Ithresh; however, any value falling within the final bracket may be selected as Ithresh without departing from the scope of the present invention.
- During some functions (e.g. Screw Tests and Detection) stimulations may stop after Ithresh is determined for the channel possessing the lowest Ithresh. For other functions (e.g. Nerve Retractor), however, it may useful to determine Ithresh for every channel. To accomplish this quickly, the hunting algorithm may employ additional methods allowing it to omit certain stimulations, thereby reducing the number of stimulations and time required to obtain an Ithresh value on each channel. Ithresh is still found using the bracketing and bisection methods described above, however the algorithm will omit stimulations for which the result is predictable from data previously acquired. When a stimulation signal is omitted, the algorithm proceeds as if the stimulation had taken place. This permits the algorithm to proceed to the next required stimulation immediately, without a time delay inherently associated with each stimulation signal. To further reduce the number of stimulations required over the time frame of an entire surgical procedure, the algorithm may confirm previously obtained Ithresh values (e.g. by stimulation at current levels just below and at/or just above Ithresh and determining whether the resulting responses are consistent with the previously acquired Ithresh value), rather than initiating stimulations from the beginning each time a function is performed.
- The final step (d) of communicating this relationship to the surgeon in an easy-to-interpret fashion may be accomplished in any number of suitable fashions, including but not limited to the use of visual indicia (such as alpha-numeric characters, light-emitting elements, and/or graphics) and audio communications (such as a speaker element). By way of example only, the determined Ithresh value may be visually displayed as a simple numerical value on
display 30. In addition, color coded graphics may be displayed to indicate the relative safety level indicated by the Ithresh (e.g. “green” for a range of stimulation thresholds below (or above, depending on the selected mode) a predetermined safe value, “red” for a range of stimulation thresholds above (or below, depending on the mode) a predetermined unsafe value, and “yellow” for the range of stimulation thresholds in between the predetermined safe and unsafe values—designating caution). When pressure sensing capabilities are added to the nerve root retractor according to one aspect of the present invention, the step of communicating the relationship to the user may also include information about the pressure being exerted upon a retracted nerve or nerve root, such as the retraction duration, the extent of retraction, and/or the resulting pressure. In one embodiment, set forth by way of example only, the information shown on thedisplay 30 may include at least some of the following components (depending on the active mode) as set forth in Table 1: -
TABLE 1 Screen Component Description Spine An image of the human body/skeleton showing the electrode placement Image on the body, with labeled channel number tabs on each side (1-4 on the left and right). Left and right labels will show the patient orientation. The channel number tabs may be highlighted or colored depending on the specific function being performed. Myotome & A label to indicate the Myotome name and corresponding Spinal Level Level(s) associated with the channel of interest. Names Menu A drop down navigation component for toggling between functions. Display Shows procedure-specific information including stimulation results. Area Color Enhances stimulation results with a color display of green, yellow, or Indication red corresponding to the relative safety level determined by the system. Mode Graphics and/or name to indicate the currently active mode (Twitch Indicator Test, Free-Run EMG, Basic Screw Test, Dynamic Screw Test, Difference Screw Test, Detection, Nerve Retractor). In an alternate embodiment, Graphics and/or name may also be displayed to indicate the instrument in use, such as the dilator, K-wire, retractor blades, screw test instruments, and associated size information, if applicable, of the cannula, with the numeric size. If no instrument is in use, then no indicator is displayed. Stimulation A graphical stimulation indicator depicting the present stimulation Bar status (i.e. on or off and stimulation current level) Sequence Shows the last seven stimulation results and provides for annotation of Bar results. EMG EMG waveforms may be optionally displayed on screen along with the waveforms stimulation results. Pressure Data regarding pressure being exerted upon a retracted nerve or nerve Indicia root, such as the duration of retraction, the extent of retraction, and/or the resulting pressure. - By way of example only, the various functional modes capable of being performed by
system 10 may include, but is not necessarily limited to, the Twitch Test, Free-run EMG, Basic Screw Test, Difference Screw Test, Dynamic Screw Test, MaXcess® Detection, Nerve Retractor, MEP Auto, MEP manual, and SSEP modes, all of which are described only briefly hereafter. The Twitch Test mode is designed to assess the neuromuscular pathway via the so-called “train-of-four test” test to ensure the neuromuscular pathway is free from muscle relaxants prior to performing neurophysiology-based testing, such as bone integrity (e.g. pedicle) testing, nerve detection, and nerve retraction. This is described in greater detail within Int'l Patent App. No. PCT/US2005/036089, entitled “System and Methods for Assessing the Neuromuscular Pathway Prior to Nerve Testing,” filed Oct. 7, 2005, the entire contents of which is hereby incorporated by reference as if set forth fully herein. The Basic Screw Test, Difference Screw Test, and Dynamic Screw Test modes are designed to assess the integrity of bone (e.g. pedicle) during all aspects of pilot hole formation (e.g., via an awl), pilot hole preparation (e.g. via a tap), and screw introduction (during and after). These modes are described in greater detail in Int'l Patent App. No. PCT/US02/35047 entitled “System and Methods for Performing Percutaneous Pedicle Integrity Assessments,” filed on Oct. 30, 2002, and PCT/US2004/025550, entitled “System and Methods for Performing Dynamic Pedicle Integrity Assessments,” filed on Aug. 5, 2004 the entire contents of which are both hereby incorporated by reference as if set forth fully herein. The MaXcess® Detection mode is designed to detect the presence of nerves during the use of the various surgical access instruments of theneuromonitoring system 10, including the k-wire 62,dilator 64,cannula 66,retractor assembly 70. This mode is described in greater detail within Int'l Patent App. No PCT/US02/22247, entitled “System and Methods for Determining Nerve Proximity, Direction, and Pathology During Surgery,” filed on Jul. 11, 2002, the entire contents of which is hereby incorporated by reference as if set forth fully herein. The MEP Auto and MEP Manual modes are designed to test the motor pathway to detect potential damage to the spinal cord by stimulating the motor cortex in the brain and recording the resulting EMG response of various muscles in the upper and lower extremities. The SSEP function is designed to test the sensory pathway to detect potential damage to the spinal cord by stimulating peripheral nerves inferior to the target spinal level and recording the action potential from sensors superior to the spinal level. The MEP Auto, MEP manual, and SSEP modes are described in greater detail within Int'l Patent App. No. PCT/US2006/003966, entitled “System and Methods for Performing Neurophysiologic Assessments During Spine Surgery,” filed on Feb. 2, 2006, the entire contents of which is hereby incorporated by reference as if set forth fully herein. The Nerve Retractor mode is designed to assess the health or pathology of a nerve before, during, and after retraction of the nerve during a surgical procedure. This mode is described in greater detail within Int'l Patent App. No. PCT/US02/30617, entitled “System and Methods for Performing Surgical Procedures and Assessments,” filed on Sep. 25, 2002, the entire contents of which is hereby incorporated by reference as if set forth fully herein. - Nerve pathology monitoring as it may be performed by the
system 10 during Nerve Retractor mode is described hereafter in more detail. Thesystem 10 preferably accomplishes neural pathology monitoring via the Nerve Retractor mode, specifically by determining a baseline stimulation threshold (again, stimulation threshold is the value Ithresh) with direct contact between thenerve retractor 29 and the nerve, prior to retraction. Subsequent stimulation thresholds are determined during retraction and they are compared to the baseline threshold. Significant changes in the stimulation threshold may indicate potential trauma to the nerve caused by the retraction and are displayed to the user on thedisplay 30. An increase in Ithresh over time is an indication that the nerve function is deteriorating. By monitoring this the surgeon may intra-operatively assess if the retracted nerve is being damaged or otherwise compromised (such as due to a prolonged surgery), such that it can be temporarily released to allow it to recover before returning to retraction to continue with the surgery. It's believed that releasing the nerve root in this fashion will prevent or reduce the adverse effects (nerve function compromise) that may otherwise result from prolonged retraction. Changes in Ithresh in the opposite direction (i.e. decreases in Ithresh over time) may indicate that the surgical procedure is improving or aiding a previously unhealthy nerve, such as during spinal decompression surgery. For accurate and timely information, Ithresh may preferably be determined for each channel according to the multi-channel hunting algorithm described above. - The nerve
root retractor assembly 28, shown in a preferred embodiment inFIGS. 8-10 , comprises thestimulation handpiece 36 employed with a selectively removablenerve root retractor 29. Thenerve root retractor 29 has a generally angled orientation relative to the longitudinal axis of thestimulation handpiece 36. Thedistal end 44 is generally curved and includes an arcuatenerve engagement surface 46 equipped with, by way of example only, at least onestimulation electrode 48. As best shown inFIG. 10 , thenerve root retractor 29 is preferably removable from thestimulation handpiece 36. To accomplish this, thestimulation handpiece 36 includes adetachable cap member 50.Threads 52 are provided on the proximal end of thenerve root retractor 29 to allow a threaded coupling engagement between thestimulation handpiece 36 and thenerve root retractor 29. During such engagement,electrical contacts 54 on thenerve root retractor 29 become electrically coupled to thestimulation handpiece 36 such that, upon activation of one or more of the buttons 38 a stimulation current signal will be transmitted from thecontrol unit 12 and/orpatient module 14 and delivered to the stimulation electrode(s) 48 on thenerve root retractor 29 for the purpose of performing neural pathology monitoring according to the present invention. Thenerve root retractor 29 is preferably disposable and, as described above, thestimulation handpiece 36 is preferably reusable and sterilizable. It should be understood that while thenerve retractor 29 is shown primarily in use with thestimulation handpiece 36 to formnerve retractor assembly 28,nerve retractor 29 may be used with any suitable handle and/or may include a fixed handle. Whennerve retractor 29 is used withoutstimulation handpiece 36 it may be coupled to thesystem 10 via one of theelectric coupling devices - In use, the
nerve root retractor 29 is introduced into or near a surgical target site in order to hook and retract a given nerve out of the way. According to the present invention, the nerve root may be stimulated (monopolar or bipolar) before, during, and/or after retraction in order to assess the degree to which such retraction impairs or otherwise degrades nerve function over time. To do so, the user may operate one ormore buttons 38 of thestimulation handpiece 36 to selectively transmit a stimulation current signal, according to the algorithm described above, from thepatient module 14 to the electrode(s) 48 on theengagement surface 46 of thenerve root retractor 29. By monitoring the myotome(s) associated with the nerve root being retracted (via the EMG harness 16) and assessing the resulting EMG responses to preferably determine Ithresh (via the control unit 12), thesystem 10 can assess whether (and the degree to which) such retraction impairs or adversely affects nerve function over time. With this information, a user may wish to periodically release the nerve root from retraction to allow nerve function to recover, thereby preventing or minimizing the risk of long-term or irreversible nerve impairment. Similarly, an unhealthy nerve may be monitored in the same manner to determine if nerve function improves due to a particular procedure, such as spinal nerve decompression surgery. - The nerve retraction monitoring feature of the present invention is best viewed with regard to
FIG. 11 . The screen display for the Nerve Retractor mode may include any of a variety of indicia capable of communicating parameters associated with the nerve retraction monitoring feature of the present invention to a surgeon, including but not limited to, channel windows containing one or more of the channel number, myotome name, spinal level, baseline Ithresh, previous Ithresh, current Ithresh, and the associated waveform, and various selection tabs for one or more of starting baseline stimulation, starting retraction stimulation, stopping stimulation, activating free-run EMG monitoring and adjusting the sensitivity of the free-run EMG, noting the retraction site, mode selection, annotating results, and remote messaging. - As described above, the nerve pathology assessments (Nerve Retractor mode) conducted by the
system 10 may be further augmented via the use of any number of pressure sensing technologies working in addition to the stimulation based nerve monitoring described above and throughout this disclosure. The pressure sensing features contemplated herein offer added safety and qualitative assessment features by providing the ability to monitor how much pressure is being applied to a particular nerve during nerve root retraction. This pressure may be a function of, among other factors, the degree of retraction (that is, distance the nerve is moved during retraction) and the duration of retraction. In any case, the pressure resulting on a nerve during retraction—if too high in magnitude and/or too long in duration—may result in neurologic deficit of varying degrees. By monitoring the pressure according to the present invention, a user may selectively reduce the degree of retraction (such as by moving theretractor assembly 28 and nerve closer to the “natural” position of the nerve) and/or periodically releasing the nerve to avoid and/or minimize any resulting neurologic deficit due to retraction. - The pressure sensing technologies may include any number of commercially available and/or publicly known pressure sensing technologies, and/or those later developed. The commercially available and/or publicly known pressure sensing technologies include, but are not necessarily limited to, the piezoelectric-based pressure sensing technique shown and described in U.S. Pat. No. 5,769,781 to James Chappuis, the capacitive-based pressure mapping system shown and described in U.S. Pat. No. 5,010,772 to Bourland et. al., the strain gauge-based pressure sensing technology shown and described in U.S. Pat. No. 4,784,150 to Voorhies et. al., the pressure sensitive ink-based technique shown and described in U.S. Pat. No. 5,989,700 to Krivopal, and that shown and described in U.S. Pat. No. 6,272,936 to Oreper et. al.
- Augmenting the nerve pathology monitoring with pressure sensing capabilities may be accomplished in any number of suitable manners, including but not limited to equipping the nerve retractor assembly 28 (and more specifically, one or more of the
nerve root retractor 29, thestimulation handpiece 36, thedistal end 44, and the nerve engagement surface 46) with one or more pressure sensing technologies. By way of example only, with reference toFIG. 9 , this may be done by equipping thenerve engagement surface 46 with apressure sensor 56. By way of example only, thepressure sensor 56 illustrated inFIG. 12 is a capacitive foam grid (comprising any number of suitable grid units) adhered tonerve engagement surface 46 ofnerve retractor 29. Whilepressure sensor 56 is shown herein having a small number of relatively large grid units, this is done for illustrative purposes. It will be readily understood by those skilled in the art that that any number of grid units and unit sizes may be utilized, andsensor 56 preferably comprises a large number of relatively small grid units to increase precision. To communicatively link thepressure sensor 56 to a processor unit, a data cable (not shown) may be run along thenerve retractor 29, and is preferably integrated within the interior ofnerve retractor 29, and from there may be connected to the processing unit viacable 58. Alternatively, wireless communication may be used to link the pressure sensor and processing unit. As will be discussed below, the processor may becontrol unit 12 or an additional dedicated processor may be employed for pressure sensing features. In use, pressure applied to the capacitive foam grid induces voltage responses corresponding to the affected grid units. The voltage responses are relayed to the processor which translates the response into one or more of numerical and/or graphical (e.g. color) indicia relating to pressure, which may be displayed to the surgeon. - According to a further embodiment of the present invention, a separate system or device may be employed for assessing or monitoring the pressure being exerted upon a nerve or nerve root before, during and/or after nerve retraction. Such a separate system may supplant (that is, take the place of) and/or augment (that is, serve in along with) the
nerve root retractor 29 equipped with pressure sensing capabilities described above. - With reference to
FIG. 13 , according to one embodiment, set forth by way of example only, the pressure sensing features of thesystem 10 are controlled via aseparate processing unit 60 while the EMG based nerve monitoring features are controlled via control unit 12 (as described throughout the description). Processingunit 60 is preferably a personal workstation or laptop computer (by way of example only) running pressure sensing software designed to interface with thepressure sensor 56 and display pressure data to the user on theprocessor screen 62. One such software program, by way of example only, is the X3 Series software distributed by XSENSOR™ Technology Corporation, Calgary Canada. In use, processingunit 60 is preferably arranged near thecontrol unit 12 such that the surgeon may view nerve pathology data from thedisplay 30 and pressure data fromscreen 62 at the same time. - As previously mentioned, pressure applied to the retracted nerve may be a function of, among other factors, the degree of retraction (that is, distance the nerve is moved during retraction) and the duration of retraction, either of which may result in neurologic deficit of varying degrees. With reference to
FIG. 14 , various pressure mapping features of the present embodiment that allow the surgeon to asses both the extent and duration of pressure applied to the retracted nerve are illustrated.FIG. 14 illustrates by way of example, a multi-function screen view of the pressure sensing software. The multi-function screen may include (by way of example only) a 2-dimensional (2-D)grid map 64, a 3-dimensional (3-D)grid map 66, and apressure distribution chart 68, and a pressure vs. time (PvT)chart 70, alegend 72, and atool bar 74. Thetool bar 74 andlegend 72 may be found on all screen views of the pressure mapping software. Thetool bar 74 allows the user to select between different view screens, among other functions (such as for example, selecting the desired sensor range and precision). Thelegend 74 indicates the numerical pressure value associated with a specific color (e.g. in one example red indicates the highest pressure of the selected range, 15.0 PSI inFIG. 14 ). -
FIGS. 15-18 illustrate exemplary embodiments of the full screen displays.FIG. 15 is a full screen display of the 2-D grid map 64, wherein various colors are used (according to the legend 72) to indicate the amount of pressure measured for each grid unit on thesensor 56. A reference marker 76 is included which corresponds to a specific corner of thepressure sensor 56, to help orient the viewer.FIG. 16 illustrates the full screen display of the 3-D grid map, wherein various colors (according to the legend 72) are again used to indicate the amount of pressure measured on the grid units ofsensor 56.FIG. 17 illustrates the full screen display of thepressure distribution graph 68, wherein the vertical axis indicates the percentage of grid units at the given moment which are under a measured pressure falling within the pressure intervals on the horizontal axis.FIG. 18 shows the full screen display of a PvT graph, wherein the maximum pressure measured onsensor 56 is charted against the retraction time. - Utilizing the various functions of the pressure mapping software, the surgeon may keep be kept aware to the extent which pressure is applied to a nerve throughout retraction, and also the length of time which a nerve is retracted. In addition, the 2-D and 3-
D maps nerve retractor 29 on the nerve. By way of example only, should either of the grid maps indicate that pressure is highest around one edge it may indicate that the nerve is not resting in the ideal position (e.g. centered and flat against the nerve engagement surface 46) and the surgeon may act to reposition the nerve relative to the nerve retractor. Pressure data collected by theprocessor 60 may preferably be viewed in real time, however, theprocessor 60 may also save the data for the entire procedure and the surgeon may go back and view any data from the same procedure at any time. - In another embodiment, set forth herein by way of example only and depicted in
FIG. 19 , the pressure sensing features of thesystem 10 are controlled via thecontrol unit 12 and the pressure features may be fully integrated with the Nerve Retractor mode described above. In this embodiment, both thepressure sensor 56 and thestimulation electrode 48 are communicatively linked to thepatient module 14 and pressure data is preferably viewed from within the Nerve Retractor screen display (discussed above with reference toFIG. 11 ). An embodiment of the Nerve Retractor screen display whensystem 10 is augmented with pressure sensing capabilities according to this embodiment is illustrated by way of example only inFIG. 20 . In the example shown, the screen display includes, among its other features, apressure selection tab 78 for initiating pressure monitoring (preferably at the same time nerve retraction) begins, amaximum pressure readout 80, and atimer readout 82. Selecting thepressure selection tab 78 using the GUI activates thepressure sensor 56 and starts the timer. The running time is displayed to the user in thetimer readout 82. The maximum pressure measured on thesensor 56 is displayed with constant real time updating. Although not shown herein, it will be appreciated that any of a number of various features such as the 2-D and 3-D grid maps, pressure distribution, and pressure vs. time graph may also be generated and displayed in this embodiment. This may be accomplished, for example only, by providing one or more pop-up windows displaying the data and/or rearranging the screen view. Pressure data measured by thesystem 10 is recorded and saved such that it may be accessed again if necessary. Pressure data may also be included in procedure reports generated by thesystem 10 such that an accurate record is easily obtained. - While the pressure sensing features herein have been described above in terms of monitoring retraction pressure on nerves it will be understood that monitoring retraction pressure may be useful for any number of different body tissues which must be retracted out of the way during surgery. By way of example only, it may be extremely beneficial to monitor retraction pressure on the larynx and/or esophagus which must be retracted during anterior cervical procedure.
- It may also be advantageous to communicate pressure related data captured by the
system 10 to persons not present in the operating room. It is contemplated that the data may be transmitted (along with the nerve pathology and other neurophysiologic assessment data) to one or more remote locations and viewable by authorized persons. This may be accomplished by any number of data transmission methods. In one example, the data may be transmitted to a remote user via remote monitoring software such as that described in detail in the commonly owned and co-pending U.S. patent application Ser. No. 11/418,589, entitled “System and Methods for Performing and Monitoring Neurophysiologic Assessments,” filed on May 5, 2006, the entire contents of which are incorporated by reference herein as if set forth in its entirety. - While this invention has been described in terms of a best mode for achieving this invention's objectives, it will be appreciated by those skilled in the art that variations may be accomplished in view of these teachings without deviating from the spirit or scope of the present invention. For example, the present invention may be implemented using any combination of computer programming software, firmware or hardware. As a preparatory step to practicing the invention or constructing an apparatus according to the invention, the computer programming code (whether software or firmware) according to the invention will typically be stored in one or more machine readable storage mediums such as fixed (hard) drives, diskettes, optical disks, magnetic tape, semiconductor memories such as ROMs, PROMs, etc., thereby making an article of manufacture in accordance with the invention. The article of manufacture containing the computer programming code is used by either executing the code directly from the storage device, by copying the code from the storage device into another storage device such as a hard disk, RAM, etc. or by transmitting the code on a network for remote execution. As can be envisioned by one of skill in the art, many different combinations of the above may be used and accordingly the present invention is not limited by the scope of the appended claims.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/294,304 US20140288389A1 (en) | 2005-07-20 | 2014-06-03 | Systems and Methods for Performing Neurophysiologic Assessments with Pressure Monitoring |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70130505P | 2005-07-20 | 2005-07-20 | |
US11/490,717 US8740783B2 (en) | 2005-07-20 | 2006-07-20 | System and methods for performing neurophysiologic assessments with pressure monitoring |
US14/294,304 US20140288389A1 (en) | 2005-07-20 | 2014-06-03 | Systems and Methods for Performing Neurophysiologic Assessments with Pressure Monitoring |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/490,717 Continuation US8740783B2 (en) | 2005-07-20 | 2006-07-20 | System and methods for performing neurophysiologic assessments with pressure monitoring |
Publications (1)
Publication Number | Publication Date |
---|---|
US20140288389A1 true US20140288389A1 (en) | 2014-09-25 |
Family
ID=37680020
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/490,717 Active 2030-01-17 US8740783B2 (en) | 2005-07-20 | 2006-07-20 | System and methods for performing neurophysiologic assessments with pressure monitoring |
US12/817,161 Abandoned US20100317989A1 (en) | 2005-07-20 | 2010-06-16 | Systems and Methods for Performing Neurophysiologic Assesments With Pressure Monitoring |
US14/294,304 Abandoned US20140288389A1 (en) | 2005-07-20 | 2014-06-03 | Systems and Methods for Performing Neurophysiologic Assessments with Pressure Monitoring |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/490,717 Active 2030-01-17 US8740783B2 (en) | 2005-07-20 | 2006-07-20 | System and methods for performing neurophysiologic assessments with pressure monitoring |
US12/817,161 Abandoned US20100317989A1 (en) | 2005-07-20 | 2010-06-16 | Systems and Methods for Performing Neurophysiologic Assesments With Pressure Monitoring |
Country Status (1)
Country | Link |
---|---|
US (3) | US8740783B2 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9533155B2 (en) | 2014-08-15 | 2017-01-03 | Axonics Modulation Technologies, Inc. | Methods for determining neurostimulation electrode configurations based on neural localization |
US9555246B2 (en) | 2014-08-15 | 2017-01-31 | Axonics Modulation Technologies, Inc. | Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder |
US10092762B2 (en) | 2014-08-15 | 2018-10-09 | Axonics Modulation Technologies, Inc. | Integrated electromyographic clinician programmer for use with an implantable neurostimulator |
US11026627B2 (en) | 2013-03-15 | 2021-06-08 | Cadwell Laboratories, Inc. | Surgical instruments for determining a location of a nerve during a procedure |
US11177610B2 (en) | 2017-01-23 | 2021-11-16 | Cadwell Laboratories, ino. | Neuromonitoring connection system |
US11253182B2 (en) | 2018-05-04 | 2022-02-22 | Cadwell Laboratories, Inc. | Apparatus and method for polyphasic multi-output constant-current and constant-voltage neurophysiological stimulation |
US11439829B2 (en) | 2019-05-24 | 2022-09-13 | Axonics, Inc. | Clinician programmer methods and systems for maintaining target operating temperatures |
US11443649B2 (en) | 2018-06-29 | 2022-09-13 | Cadwell Laboratories, Inc. | Neurophysiological monitoring training simulator |
US11701047B2 (en) | 2017-06-16 | 2023-07-18 | Alphatec Spine, Inc. | Systems, methods, and devices for detecting the threshold of nerve-muscle response using variable frequency of stimulation |
US11848090B2 (en) | 2019-05-24 | 2023-12-19 | Axonics, Inc. | Trainer for a neurostimulator programmer and associated methods of use with a neurostimulation system |
US11963775B2 (en) | 2017-03-22 | 2024-04-23 | Safeop Surgical, Inc. | Medical systems and methods for detecting changes in electrophysiological evoked potentials |
US11963784B2 (en) | 2013-11-07 | 2024-04-23 | Safeop Surgical, Inc. | Systems and methods for detecting nerve function |
US11986321B2 (en) | 2016-09-22 | 2024-05-21 | Safeop Surgical, Inc. | System and method for detecting and removing periodic non-physiological artifact from evoked potentials |
US11992339B2 (en) | 2018-05-04 | 2024-05-28 | Cadwell Laboratories, Inc. | Systems and methods for dynamic neurophysiological stimulation |
US12048567B2 (en) | 2015-05-04 | 2024-07-30 | Safeop Surgical, Inc. | System, method, and computer algorithm for measuring, displaying, and accurately detecting changes in electrophysiological evoked potentials |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4854900B2 (en) | 1999-11-24 | 2012-01-18 | ヌバシブ, インコーポレイテッド | EMG measurement method |
JP4295086B2 (en) | 2001-07-11 | 2009-07-15 | ヌバシブ, インコーポレイテッド | System and method for determining nerve proximity, nerve orientation, and pathology during surgery |
EP1435828A4 (en) | 2001-09-25 | 2009-11-11 | Nuvasive Inc | System and methods for performing surgical procedures and assessments |
US7582058B1 (en) | 2002-06-26 | 2009-09-01 | Nuvasive, Inc. | Surgical access system and related methods |
US8137284B2 (en) | 2002-10-08 | 2012-03-20 | Nuvasive, Inc. | Surgical access system and related methods |
US7691057B2 (en) | 2003-01-16 | 2010-04-06 | Nuvasive, Inc. | Surgical access system and related methods |
US7819801B2 (en) | 2003-02-27 | 2010-10-26 | Nuvasive, Inc. | Surgical access system and related methods |
US7905840B2 (en) * | 2003-10-17 | 2011-03-15 | Nuvasive, Inc. | Surgical access system and related methods |
EP1680177B1 (en) | 2003-09-25 | 2017-04-12 | NuVasive, Inc. | Surgical access system |
US8313430B1 (en) | 2006-01-11 | 2012-11-20 | Nuvasive, Inc. | Surgical access system and related methods |
US9795367B1 (en) * | 2003-10-17 | 2017-10-24 | Nuvasive, Inc. | Surgical access system and related methods |
WO2007038290A2 (en) * | 2005-09-22 | 2007-04-05 | Nuvasive, Inc. | Multi-channel stimulation threshold detection algorithm for use in neurophysiology monitoring |
AU2008236665B2 (en) * | 2007-04-03 | 2013-08-22 | Nuvasive, Inc. | Neurophysiologic monitoring system |
BRPI0818608A2 (en) | 2007-10-05 | 2015-04-22 | Synthes Gmbh | Sequential directional dilatation system for dilating from a nerve of a patient's anatomy, and method for forming an access opening through a psoas muscle to a patient's spine using a dilatation system |
US7811138B2 (en) * | 2008-02-29 | 2010-10-12 | Pioneer Surgical Technology, Inc. | Electrical connector for surgical systems |
US8137285B1 (en) * | 2008-08-26 | 2012-03-20 | Rhythmlink International, Llc | Monopolar stimulation probe system |
WO2010044880A1 (en) * | 2008-10-15 | 2010-04-22 | Nuvasive, Inc. | Neurophysiologic monitoring system and related methods |
US9084551B2 (en) | 2008-12-08 | 2015-07-21 | Medtronic Xomed, Inc. | Method and system for monitoring a nerve |
CA2750917A1 (en) | 2008-12-26 | 2010-07-01 | Scott Spann | Minimally-invasive retroperitoneal lateral approach for spinal surgery |
AU2010247953A1 (en) * | 2009-05-11 | 2012-01-12 | Hyun Woo Bae | Neurologic monitoring system and method |
US20110230785A1 (en) * | 2010-03-16 | 2011-09-22 | ProNerve, LLC | Somatosensory Evoked Potential (SSEP) Automated Alert System |
US9392953B1 (en) * | 2010-09-17 | 2016-07-19 | Nuvasive, Inc. | Neurophysiologic monitoring |
WO2012040206A1 (en) | 2010-09-20 | 2012-03-29 | Synthes Usa, Llc | Spinal access retractor |
US9155503B2 (en) * | 2010-10-27 | 2015-10-13 | Cadwell Labs | Apparatus, system, and method for mapping the location of a nerve |
US9808232B2 (en) | 2011-11-01 | 2017-11-07 | DePuy Synthes Products, Inc. | Dilation system |
US9265490B2 (en) | 2012-04-16 | 2016-02-23 | DePuy Synthes Products, Inc. | Detachable dilator blade |
US11259737B2 (en) | 2012-11-06 | 2022-03-01 | Nuvasive, Inc. | Systems and methods for performing neurophysiologic monitoring during spine surgery |
US11877860B2 (en) | 2012-11-06 | 2024-01-23 | Nuvasive, Inc. | Systems and methods for performing neurophysiologic monitoring during spine surgery |
US9757067B1 (en) | 2012-11-09 | 2017-09-12 | Nuvasive, Inc. | Systems and methods for performing neurophysiologic monitoring during spine surgery |
US9757072B1 (en) | 2013-02-11 | 2017-09-12 | Nuvasive, Inc. | Waveform marker placement algorithm for use in neurophysiologic monitoring |
US11229789B2 (en) | 2013-05-30 | 2022-01-25 | Neurostim Oab, Inc. | Neuro activator with controller |
JP2016523125A (en) | 2013-05-30 | 2016-08-08 | グラハム エイチ. クリーシー | Local nervous stimulation |
FR3010628B1 (en) | 2013-09-18 | 2015-10-16 | Medicrea International | METHOD FOR REALIZING THE IDEAL CURVATURE OF A ROD OF A VERTEBRAL OSTEOSYNTHESIS EQUIPMENT FOR STRENGTHENING THE VERTEBRAL COLUMN OF A PATIENT |
FR3012030B1 (en) | 2013-10-18 | 2015-12-25 | Medicrea International | METHOD FOR REALIZING THE IDEAL CURVATURE OF A ROD OF A VERTEBRAL OSTEOSYNTHESIS EQUIPMENT FOR STRENGTHENING THE VERTEBRAL COLUMN OF A PATIENT |
US10258228B2 (en) | 2014-08-08 | 2019-04-16 | K2M, Inc. | Retraction devices, systems, and methods for minimally invasive spinal surgery |
US10420480B1 (en) | 2014-09-16 | 2019-09-24 | Nuvasive, Inc. | Systems and methods for performing neurophysiologic monitoring |
US11077301B2 (en) | 2015-02-21 | 2021-08-03 | NeurostimOAB, Inc. | Topical nerve stimulator and sensor for bladder control |
US10433793B1 (en) | 2015-03-27 | 2019-10-08 | Cadwell Laboratories, Inc. | Methods and systems for simultaneous review of brain activity and physical manifestations of users |
WO2017079655A2 (en) | 2015-11-04 | 2017-05-11 | Mcafee Paul C | Methods and apparatus for spinal reconstructive surgery and measuring spinal length and intervertebral spacing, tension and rotation |
US9801582B2 (en) * | 2015-11-12 | 2017-10-31 | King Saud University | Thigh adhesion quantitative measurement system |
WO2018109556A1 (en) | 2016-12-12 | 2018-06-21 | Medicrea International | Systems and methods for patient-specific spinal implants |
US11241297B2 (en) | 2016-12-12 | 2022-02-08 | Cadwell Laboratories, Inc. | System and method for high density electrode management |
JP7165668B2 (en) | 2017-04-21 | 2022-11-04 | メディクレア インターナショナル | System for developing one or more patient-specific spinal implants |
EP3706856A4 (en) | 2017-11-07 | 2021-08-18 | Neurostim Oab, Inc. | Non-invasive nerve activator with adaptive circuit |
US10918422B2 (en) | 2017-12-01 | 2021-02-16 | Medicrea International | Method and apparatus for inhibiting proximal junctional failure |
US11517239B2 (en) | 2018-04-05 | 2022-12-06 | Cadwell Laboratories, Inc. | Systems and methods for processing and displaying electromyographic signals |
US11596337B2 (en) | 2018-04-24 | 2023-03-07 | Cadwell Laboratories, Inc | Methods and systems for operating an intraoperative neurophysiological monitoring system in conjunction with electrocautery procedures |
US11185684B2 (en) | 2018-09-18 | 2021-11-30 | Cadwell Laboratories, Inc. | Minimally invasive two-dimensional grid electrode |
US11517245B2 (en) | 2018-10-30 | 2022-12-06 | Cadwell Laboratories, Inc. | Method and system for data synchronization |
EP3873336A1 (en) | 2018-10-31 | 2021-09-08 | Stryker Corporation | System and method for monitoring nerve activity within a trachea of a patient |
US11471087B2 (en) | 2018-11-09 | 2022-10-18 | Cadwell Laboratories, Inc. | Integrity verification system for testing high channel count neuromonitoring recording equipment |
US11317841B2 (en) | 2018-11-14 | 2022-05-03 | Cadwell Laboratories, Inc. | Method and system for electrode verification |
US11529107B2 (en) | 2018-11-27 | 2022-12-20 | Cadwell Laboratories, Inc. | Methods for automatic generation of EEG montages |
US11128076B2 (en) | 2019-01-21 | 2021-09-21 | Cadwell Laboratories, Inc. | Connector receptacle |
US11877801B2 (en) | 2019-04-02 | 2024-01-23 | Medicrea International | Systems, methods, and devices for developing patient-specific spinal implants, treatments, operations, and/or procedures |
US11925417B2 (en) | 2019-04-02 | 2024-03-12 | Medicrea International | Systems, methods, and devices for developing patient-specific spinal implants, treatments, operations, and/or procedures |
EP3990100A4 (en) | 2019-06-26 | 2023-07-19 | Neurostim Technologies LLC | Non-invasive nerve activator with adaptive circuit |
CA3152451A1 (en) | 2019-12-16 | 2021-06-24 | Michael Bernard Druke | Non-invasive nerve activator with boosted charge delivery |
US11769251B2 (en) | 2019-12-26 | 2023-09-26 | Medicrea International | Systems and methods for medical image analysis |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4795998A (en) * | 1984-05-04 | 1989-01-03 | Raychem Limited | Sensor array |
US5085226A (en) * | 1990-05-30 | 1992-02-04 | Trustees Of Boston University | Force monitoring apparatus for back muscles |
US5163328A (en) * | 1990-08-06 | 1992-11-17 | Colin Electronics Co., Ltd. | Miniature pressure sensor and pressure sensor arrays |
US5201325A (en) * | 1989-09-01 | 1993-04-13 | Andronic Devices Ltd. | Advanced surgical retractor |
US5253656A (en) * | 1991-05-23 | 1993-10-19 | Rincoe Richard G | Apparatus and method for monitoring contact pressure between body parts and contact surfaces |
US5924984A (en) * | 1997-01-30 | 1999-07-20 | University Of Iowa Research Foundation | Anorectal probe apparatus having at least one muscular activity sensor |
US20020194934A1 (en) * | 2001-06-26 | 2002-12-26 | Taylor Geoffrey L. | Pressure measurement sensor with piezoresistive thread lattice |
US6500210B1 (en) * | 1992-09-08 | 2002-12-31 | Seattle Systems, Inc. | System and method for providing a sense of feel in a prosthetic or sensory impaired limb |
WO2003005887A2 (en) * | 2001-07-11 | 2003-01-23 | Nuvasive, Inc. | System and methods for determining nerve proximity, direction, and pathology during surgery |
US6511427B1 (en) * | 2000-03-10 | 2003-01-28 | Acuson Corporation | System and method for assessing body-tissue properties using a medical ultrasound transducer probe with a body-tissue parameter measurement mechanism |
US20030212335A1 (en) * | 2002-03-02 | 2003-11-13 | Huang Herb H. | Pulse diagnostic system |
WO2003094744A1 (en) * | 2002-05-09 | 2003-11-20 | Tyco Healthcare Group Lp | Endoscopic organ retractor and method of using the same |
US20040068203A1 (en) * | 2002-10-03 | 2004-04-08 | Scimed Life Systems, Inc. | Sensing pressure |
US20040230131A1 (en) * | 2003-02-21 | 2004-11-18 | Kassab Ghassan S. | System and method for measuring cross-sectional areas and pressure gradients in luminal organs |
Family Cites Families (190)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2736002A (en) * | 1956-02-21 | oriel | ||
US972983A (en) | 1909-05-17 | 1910-10-18 | Lester R Lantz | Dilator. |
US1328624A (en) * | 1917-08-13 | 1920-01-20 | Frank B Graham | Dilator |
US1548184A (en) | 1923-04-11 | 1925-08-04 | Will J Cameron | Holder and control for pulp testers |
US2704064A (en) * | 1952-09-10 | 1955-03-15 | Meditron Company | Neurosurgical stimulator |
US2808826A (en) | 1956-01-19 | 1957-10-08 | Teca Corp | Electro-diagnostic apparatus and a circuit therefor |
US3364929A (en) * | 1964-12-21 | 1968-01-23 | Burroughs Wellcome Co | Method for administering muscle relaxant drug |
US3682162A (en) | 1968-12-13 | 1972-08-08 | Wellcome Found | Combined electrode and hypodermic syringe needle |
US3664329A (en) * | 1970-03-09 | 1972-05-23 | Concept | Nerve locator/stimulator |
US3785368A (en) * | 1971-08-23 | 1974-01-15 | Carthy T Mc | Abnormal nerve pressure locus detector and method |
US3830226A (en) | 1973-06-15 | 1974-08-20 | Concept | Variable output nerve locator |
US3957036A (en) * | 1975-02-03 | 1976-05-18 | Baylor College Of Medicine | Method and apparatus for recording activity in intact nerves |
GB1534162A (en) * | 1976-07-21 | 1978-11-29 | Lloyd J | Cyosurgical probe |
US4099519A (en) * | 1977-01-14 | 1978-07-11 | Warren Fred E | Diagnostic device |
US4164214A (en) | 1977-07-25 | 1979-08-14 | The Regents Of The University Of California | Method and apparatus for measuring the sensitivity of teeth |
US4224949A (en) | 1977-11-17 | 1980-09-30 | Cornell Research Foundation, Inc. | Method and electrical resistance probe for detection of estrus in bovine |
US4226228A (en) | 1978-11-02 | 1980-10-07 | Shin Hee J | Multiple joint retractor with light |
US4235242A (en) | 1979-04-02 | 1980-11-25 | Med General, Inc. | Electronic circuit permitting simultaneous use of stimulating and monitoring equipment |
US4285347A (en) | 1979-07-25 | 1981-08-25 | Cordis Corporation | Stabilized directional neural electrode lead |
US4291705A (en) | 1979-09-10 | 1981-09-29 | The Regents Of The University Of California | Neuromuscular block monitor |
USRE34390E (en) | 1980-12-31 | 1993-09-28 | Nicolet Instrument Corporation | Apparatus and method for topographic display of multichannel EEG data |
US4461300A (en) * | 1982-01-18 | 1984-07-24 | Sutter Biomedical, Inc. | Bone and tissue healing device including a special electrode assembly and method |
US4592369A (en) * | 1982-07-12 | 1986-06-03 | National Research Development Corp. | Method and apparatus for use in temporal analysis of waveforms |
US4545374A (en) | 1982-09-03 | 1985-10-08 | Jacobson Robert E | Method and instruments for performing a percutaneous lumbar diskectomy |
US4519403A (en) * | 1983-04-29 | 1985-05-28 | Medtronic, Inc. | Balloon lead and inflator |
US4561445A (en) | 1983-05-25 | 1985-12-31 | Joseph J. Berke | Elongated needle electrode and method of making same |
FI73878C (en) * | 1983-06-10 | 1987-12-10 | Instrumentarium Oy | FOERFARANDE FOER VIDAREUTVECKLING AV NERVMUSKELANSLUTNINGS MAETNING. |
US4515168A (en) * | 1983-07-22 | 1985-05-07 | Chester Martin H | Clamp-on nerve stimulator and locator |
US4573448A (en) * | 1983-10-05 | 1986-03-04 | Pilling Co. | Method for decompressing herniated intervertebral discs |
US4562832A (en) * | 1984-01-21 | 1986-01-07 | Wilder Joseph R | Medical instrument and light pipe illumination assembly |
US4616660A (en) | 1984-12-10 | 1986-10-14 | Suncoast Medical Manufacturing, Inc. | Variable alternating current output nerve locator/stimulator |
US4633889A (en) * | 1984-12-12 | 1987-01-06 | Andrew Talalla | Stimulation of cauda-equina spinal nerves |
US4658835A (en) * | 1985-07-25 | 1987-04-21 | Cordis Corporation | Neural stimulating lead with fixation canopy formation |
WO1987001023A1 (en) * | 1985-08-16 | 1987-02-26 | David Brown | Electromyographic repetitive strain injury monitor |
US4892105A (en) * | 1986-03-28 | 1990-01-09 | The Cleveland Clinic Foundation | Electrical stimulus probe |
US4784150A (en) | 1986-11-04 | 1988-11-15 | Research Corporation | Surgical retractor and blood flow monitor |
US4759377A (en) | 1986-11-26 | 1988-07-26 | Regents Of The University Of Minnesota | Apparatus and method for mechanical stimulation of nerves |
US4744371A (en) * | 1987-04-27 | 1988-05-17 | Cordis Leads, Inc. | Multi-conductor lead assembly for temporary use |
US4926865A (en) * | 1987-10-01 | 1990-05-22 | Oman Paul S | Microcomputer-based nerve and muscle stimulator |
DE8803153U1 (en) * | 1988-03-09 | 1988-06-23 | B. Braun Melsungen Ag, 3508 Melsungen | Catheter device for plexus anesthesia |
US5772661A (en) * | 1988-06-13 | 1998-06-30 | Michelson; Gary Karlin | Methods and instrumentation for the surgical correction of human thoracic and lumbar spinal disease from the antero-lateral aspect of the spine |
US5015247A (en) * | 1988-06-13 | 1991-05-14 | Michelson Gary K | Threaded spinal implant |
US6770074B2 (en) | 1988-06-13 | 2004-08-03 | Gary Karlin Michelson | Apparatus for use in inserting spinal implants |
US5484437A (en) * | 1988-06-13 | 1996-01-16 | Michelson; Gary K. | Apparatus and method of inserting spinal implants |
US5127403A (en) | 1988-07-05 | 1992-07-07 | Cardiac Control Systems, Inc. | Pacemaker catheter utilizing bipolar electrodes spaced in accordance to the length of a heart depolarization signal |
US5058602A (en) | 1988-09-30 | 1991-10-22 | Brody Stanley R | Paraspinal electromyography scanning |
US4964411A (en) | 1989-07-13 | 1990-10-23 | Empi, Inc. | Evoked EMG signal processing |
US4962766A (en) | 1989-07-19 | 1990-10-16 | Herzon Garrett D | Nerve locator and stimulator |
US5125406A (en) * | 1989-11-29 | 1992-06-30 | Eet Limited Partnership (Del) | Electrode endotracheal tube |
US5454365A (en) * | 1990-11-05 | 1995-10-03 | Bonutti; Peter M. | Mechanically expandable arthroscopic retractors |
US5081990A (en) * | 1990-05-11 | 1992-01-21 | New York University | Catheter for spinal epidural injection of drugs and measurement of evoked potentials |
US5095905A (en) * | 1990-06-07 | 1992-03-17 | Medtronic, Inc. | Implantable neural electrode |
US5092344A (en) * | 1990-11-19 | 1992-03-03 | Lee Tzium Shou | Remote indicator for stimulator |
SE467561B (en) * | 1990-12-04 | 1992-08-10 | Dorsograf Ab | DEVICE FOR SEATING TRANSPORT TIME OF NERV SIGNALS |
US5480440A (en) * | 1991-08-15 | 1996-01-02 | Smith & Nephew Richards, Inc. | Open surgical technique for vertebral fixation with subcutaneous fixators positioned between the skin and the lumbar fascia of a patient |
US5161533A (en) | 1991-09-19 | 1992-11-10 | Xomed-Treace Inc. | Break-apart needle electrode system for monitoring facial EMG |
US5313962A (en) * | 1991-10-18 | 1994-05-24 | Obenchain Theodore G | Method of performing laparoscopic lumbar discectomy |
US5255691A (en) | 1991-11-13 | 1993-10-26 | Medtronic, Inc. | Percutaneous epidural lead introducing system and method |
US6500173B2 (en) | 1992-01-07 | 2002-12-31 | Ronald A. Underwood | Methods for electrosurgical spine surgery |
US5171279A (en) | 1992-03-17 | 1992-12-15 | Danek Medical | Method for subcutaneous suprafascial pedicular internal fixation |
US5284153A (en) * | 1992-04-14 | 1994-02-08 | Brigham And Women's Hospital | Method for locating a nerve and for protecting nerves from injury during surgery |
US5196015A (en) * | 1992-04-30 | 1993-03-23 | Neubardt Seth L | Procedure for spinal pedicle screw insertion |
US5474558A (en) | 1992-04-30 | 1995-12-12 | Neubardt; Seth L. | Procedure and system for spinal pedicle screw insertion |
US5312417A (en) * | 1992-07-29 | 1994-05-17 | Wilk Peter J | Laparoscopic cannula assembly and associated method |
US5299563A (en) * | 1992-07-31 | 1994-04-05 | Seton Joseph Z | Method of using a surgical retractor |
US5772597A (en) | 1992-09-14 | 1998-06-30 | Sextant Medical Corporation | Surgical tool end effector |
EP0719113A1 (en) * | 1992-11-13 | 1996-07-03 | American Cardiac Ablation Co., Inc. | Fluid cooled electrosurgical probe |
US5375067A (en) | 1992-12-11 | 1994-12-20 | Nicolet Instrument Corporation | Method and apparatus for adjustment of acquisition parameters in a data acquisition system such as a digital oscilloscope |
US5814073A (en) | 1996-12-13 | 1998-09-29 | Bonutti; Peter M. | Method and apparatus for positioning a suture anchor |
US5327902A (en) | 1993-05-14 | 1994-07-12 | Lemmen Roger D | Apparatus for use in nerve conduction studies |
US5333618A (en) | 1993-06-30 | 1994-08-02 | Gregory Lekhtman | Portable self-contained instrument for the measurement of nerve resistance of a patient |
US5549656A (en) | 1993-08-16 | 1996-08-27 | Med Serve Group, Inc. | Combination neuromuscular stimulator and electromyograph system |
US5566678B1 (en) | 1993-09-10 | 1999-11-30 | Cadwell Ind Inc | Digital eeg noise synthesizer |
US5560372A (en) | 1994-02-02 | 1996-10-01 | Cory; Philip C. | Non-invasive, peripheral nerve mapping device and method of use |
CA2144211C (en) * | 1994-03-16 | 2005-05-24 | David T. Green | Surgical instruments useful for endoscopic spinal procedures |
CA2551185C (en) | 1994-03-28 | 2007-10-30 | Sdgi Holdings, Inc. | Apparatus and method for anterior spinal stabilization |
US5575284A (en) * | 1994-04-01 | 1996-11-19 | University Of South Florida | Portable pulse oximeter |
US5482038A (en) * | 1994-06-28 | 1996-01-09 | Cadwell Industries, Inc. | Needle electrode assembly |
US5593429A (en) * | 1994-06-28 | 1997-01-14 | Cadwell Industries, Inc. | Needle electrode with depth of penetration limiter |
US5540235A (en) | 1994-06-30 | 1996-07-30 | Wilson; John R. | Adaptor for neurophysiological monitoring with a personal computer |
US6038469A (en) * | 1994-10-07 | 2000-03-14 | Ortivus Ab | Myocardial ischemia and infarction analysis and monitoring method and apparatus |
US5579781A (en) | 1994-10-13 | 1996-12-03 | Cooke; Thomas H. | Wireless transmitter for needle electrodes as used in electromyography |
US5630813A (en) * | 1994-12-08 | 1997-05-20 | Kieturakis; Maciej J. | Electro-cauterizing dissector and method for facilitating breast implant procedure |
US5601608A (en) * | 1995-02-02 | 1997-02-11 | Pacesetter, Inc. | Methods and apparatus for applying charge-balanced antiarrhythmia shocks |
US5860973A (en) * | 1995-02-27 | 1999-01-19 | Michelson; Gary Karlin | Translateral spinal implant |
US5671752A (en) | 1995-03-31 | 1997-09-30 | Universite De Montreal/The Royal Insitution For The Advancement Of Learning (Mcgill University) | Diaphragm electromyography analysis method and system |
WO1996032156A1 (en) | 1995-04-10 | 1996-10-17 | St. Luke's-Roosevelt Hospital | Peripheral nerve stimulation device for unassisted nerve blockade |
US5711307A (en) * | 1995-04-13 | 1998-01-27 | Liberty Mutual Insurance Company | Method and apparatus for detecting myoelectric activity from the surface of the skin |
US5775331A (en) | 1995-06-07 | 1998-07-07 | Uromed Corporation | Apparatus and method for locating a nerve |
DE29510204U1 (en) * | 1995-06-23 | 1995-08-31 | Aesculap Ag, 78532 Tuttlingen | Surgical retractor |
US5797854A (en) | 1995-08-01 | 1998-08-25 | Hedgecock; James L. | Method and apparatus for testing and measuring current perception threshold and motor nerve junction performance |
DE19530869A1 (en) | 1995-08-22 | 1997-02-27 | Sterimed Gmbh | Puncturing and / or catheterizing device for probing nerves |
US5769781A (en) * | 1995-11-13 | 1998-06-23 | Chappuis; James L. | Protector retractor |
US5707359A (en) * | 1995-11-14 | 1998-01-13 | Bufalini; Bruno | Expanding trocar assembly |
US6425901B1 (en) | 1995-12-07 | 2002-07-30 | Loma Linda University Medical Center | Vascular wound closure system |
US5779642A (en) | 1996-01-16 | 1998-07-14 | Nightengale; Christopher | Interrogation device and method |
US5792044A (en) | 1996-03-22 | 1998-08-11 | Danek Medical, Inc. | Devices and methods for percutaneous surgery |
DE19618945C2 (en) | 1996-05-10 | 2003-02-27 | Phonak Ag Staefa | Fixable positioning system for a firm, play-free connection to the human skull |
US5853373A (en) | 1996-08-05 | 1998-12-29 | Becton, Dickinson And Company | Bi-level charge pulse apparatus to facilitate nerve location during peripheral nerve block procedures |
US5759159A (en) * | 1996-09-25 | 1998-06-02 | Ormco Corporation | Method and apparatus for apical detection with complex impedance measurement |
US5862314A (en) * | 1996-11-01 | 1999-01-19 | Micron Electronics, Inc. | System and method for remapping defective memory locations |
US6135965A (en) | 1996-12-02 | 2000-10-24 | Board Of Regents, The University Of Texas System | Spectroscopic detection of cervical pre-cancer using radial basis function networks |
BR9604655C1 (en) * | 1996-12-05 | 1999-12-28 | Waldir Teixeira Reno | Grid retractor for surgery. |
US6119068A (en) | 1996-12-27 | 2000-09-12 | Kannonji; Michihiro | Rear-end collision alarming device and method linked to speed control device of a vehicle |
US5928158A (en) | 1997-03-25 | 1999-07-27 | Aristides; Arellano | Medical instrument with nerve sensor |
US6050992A (en) * | 1997-05-19 | 2000-04-18 | Radiotherapeutics Corporation | Apparatus and method for treating tissue with multiple electrodes |
US6132387A (en) | 1997-07-01 | 2000-10-17 | Neurometrix, Inc. | Neuromuscular electrode |
US6146335A (en) | 1997-07-01 | 2000-11-14 | Neurometrix, Inc. | Apparatus for methods for the assessment of neuromuscular function of the lower extremity |
US6132386A (en) | 1997-07-01 | 2000-10-17 | Neurometrix, Inc. | Methods for the assessment of neuromuscular function by F-wave latency |
US5851191A (en) | 1997-07-01 | 1998-12-22 | Neurometrix, Inc. | Apparatus and methods for assessment of neuromuscular function |
US5872314A (en) * | 1997-07-25 | 1999-02-16 | Clinton; Robert P. | Method and apparatus for measuring characteristics of meat |
US6348058B1 (en) * | 1997-12-12 | 2002-02-19 | Surgical Navigation Technologies, Inc. | Image guided spinal surgery guide, system, and method for use thereof |
US6306100B1 (en) | 1997-12-16 | 2001-10-23 | Richard L. Prass | Intraoperative neurophysiological monitoring system |
US6181961B1 (en) * | 1997-12-16 | 2001-01-30 | Richard L. Prass | Method and apparatus for an automatic setup of a multi-channel nerve integrity monitoring system |
US6206826B1 (en) * | 1997-12-18 | 2001-03-27 | Sdgi Holdings, Inc. | Devices and methods for percutaneous surgery |
US5928139A (en) | 1998-04-24 | 1999-07-27 | Koros; Tibor B. | Retractor with adjustable length blades and light pipe guides |
US6161047A (en) | 1998-04-30 | 2000-12-12 | Medtronic Inc. | Apparatus and method for expanding a stimulation lead body in situ |
US6004262A (en) | 1998-05-04 | 1999-12-21 | Ad-Tech Medical Instrument Corp. | Visually-positioned electrical monitoring apparatus |
US6139493A (en) | 1998-07-08 | 2000-10-31 | Koros; Tibor B. | Retractor with adjustable length blades and light pipe guides |
US6027456A (en) * | 1998-07-10 | 2000-02-22 | Advanced Neuromodulation Systems, Inc. | Apparatus and method for positioning spinal cord stimulation leads |
JP2000028717A (en) | 1998-07-13 | 2000-01-28 | Mitsubishi Electric Corp | Device for detecting obstacle |
US6104960A (en) | 1998-07-13 | 2000-08-15 | Medtronic, Inc. | System and method for providing medical electrical stimulation to a portion of the nervous system |
US6126660A (en) | 1998-07-29 | 2000-10-03 | Sofamor Danek Holdings, Inc. | Spinal compression and distraction devices and surgical methods |
US6366813B1 (en) | 1998-08-05 | 2002-04-02 | Dilorenzo Daniel J. | Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease |
US6292701B1 (en) | 1998-08-12 | 2001-09-18 | Medtronic Xomed, Inc. | Bipolar electrical stimulus probe with planar electrodes |
US6104957A (en) | 1998-08-21 | 2000-08-15 | Alo; Kenneth M. | Epidural nerve root stimulation with lead placement method |
US6139545A (en) | 1998-09-09 | 2000-10-31 | Vidaderm | Systems and methods for ablating discrete motor nerve regions |
US6038477A (en) * | 1998-12-23 | 2000-03-14 | Axon Engineering, Inc. | Multiple channel nerve stimulator with channel isolation |
JP4430238B2 (en) | 1998-09-18 | 2010-03-10 | 英博 山本 | Endoscope electrification device |
US6451015B1 (en) | 1998-11-18 | 2002-09-17 | Sherwood Services Ag | Method and system for menu-driven two-dimensional display lesion generator |
US6507755B1 (en) * | 1998-12-01 | 2003-01-14 | Neurometrix, Inc. | Apparatus and method for stimulating human tissue |
US6266558B1 (en) | 1998-12-01 | 2001-07-24 | Neurometrix, Inc. | Apparatus and method for nerve conduction measurements with automatic setting of stimulus intensity |
US6564078B1 (en) * | 1998-12-23 | 2003-05-13 | Nuvasive, Inc. | Nerve surveillance cannula systems |
ATE306213T1 (en) | 1998-12-23 | 2005-10-15 | Nuvasive Inc | DEVICES FOR CANNULATION AND NERVE MONITORING |
US6393325B1 (en) * | 1999-01-07 | 2002-05-21 | Advanced Bionics Corporation | Directional programming for implantable electrode arrays |
US6312451B1 (en) | 1999-03-23 | 2001-11-06 | Jackson Streeter | Low level laser therapy apparatus |
US6074343A (en) * | 1999-04-16 | 2000-06-13 | Nathanson; Michael | Surgical tissue retractor |
US6224549B1 (en) * | 1999-04-20 | 2001-05-01 | Nicolet Biomedical, Inc. | Medical signal monitoring and display |
US6259945B1 (en) * | 1999-04-30 | 2001-07-10 | Uromed Corporation | Method and device for locating a nerve |
US6901928B2 (en) | 1999-05-04 | 2005-06-07 | Paul G. Loubser | Superglottic and peri-laryngeal apparatus for supraglottic airway insertion |
DE29908259U1 (en) | 1999-05-07 | 1999-07-15 | Aesculap AG & Co. KG, 78532 Tuttlingen | Rotating surgical tool |
ES2270814T3 (en) * | 1999-05-07 | 2007-04-16 | AESCULAP AG & CO. KG | ROTATING SURGICAL TOOL. |
FR2795624B1 (en) | 1999-07-01 | 2001-09-28 | Vanacker Gerard | METHOD FOR DRILLING THE VERTEBRAL PEDICLE, PARTICULARLY FOR THE PLACEMENT OF A PEDICULAR SCREW, AN INSTRUMENT FOR THE IMPLEMENTATION OF SUCH A PROCESS |
FR2796846A1 (en) | 1999-07-30 | 2001-02-02 | Mohamed Zouheir Naja | Thoraco-abdominal or pelvic anaesthesia apparatus comprises needle and electrode linked to electrical power source, extension, guide tube and catheter |
US6334068B1 (en) | 1999-09-14 | 2001-12-25 | Medtronic Xomed, Inc. | Intraoperative neuroelectrophysiological monitor |
US6546271B1 (en) * | 1999-10-01 | 2003-04-08 | Bioscience, Inc. | Vascular reconstruction |
US20050256582A1 (en) | 1999-10-08 | 2005-11-17 | Ferree Bret A | Spinal implants, including devices that reduce pressure on the annulus fibrosis |
US6500180B1 (en) * | 1999-10-20 | 2002-12-31 | Sdgi Holdings, Inc. | Methods and instrumentation for distraction of a disc space |
JP4854900B2 (en) | 1999-11-24 | 2012-01-18 | ヌバシブ, インコーポレイテッド | EMG measurement method |
US6466817B1 (en) | 1999-11-24 | 2002-10-15 | Nuvasive, Inc. | Nerve proximity and status detection system and method |
US6582441B1 (en) * | 2000-02-24 | 2003-06-24 | Advanced Bionics Corporation | Surgical insertion tool |
US6312392B1 (en) | 2000-04-06 | 2001-11-06 | Garrett D. Herzon | Bipolar handheld nerve locator and evaluator |
WO2001087154A1 (en) * | 2000-05-18 | 2001-11-22 | Nuvasive, Inc. | Tissue discrimination and applications in medical procedures |
AU6976801A (en) * | 2000-06-08 | 2001-12-17 | Nuvasive Inc | Relative nerve movement and status detection system and method |
WO2002013714A1 (en) * | 2000-08-17 | 2002-02-21 | Image Guided Neurologies, Inc. | Trajectory guide with instrument immobilizer |
US6487446B1 (en) | 2000-09-26 | 2002-11-26 | Medtronic, Inc. | Method and system for spinal cord stimulation prior to and during a medical procedure |
US7089059B1 (en) | 2000-11-03 | 2006-08-08 | Pless Benjamin D | Predicting susceptibility to neurological dysfunction based on measured neural electrophysiology |
US6847849B2 (en) * | 2000-11-15 | 2005-01-25 | Medtronic, Inc. | Minimally invasive apparatus for implanting a sacral stimulation lead |
US20080039914A1 (en) | 2000-11-24 | 2008-02-14 | Nervonix, Inc. | Needle with depth determination capability and method of use |
US6346078B1 (en) * | 2000-12-04 | 2002-02-12 | Alan G. Ellman | Eyelid retractor for electrosurgery |
US6618626B2 (en) | 2001-01-16 | 2003-09-09 | Hs West Investments, Llc | Apparatus and methods for protecting the axillary nerve during thermal capsullorhaphy |
US6929606B2 (en) | 2001-01-29 | 2005-08-16 | Depuy Spine, Inc. | Retractor and method for spinal pedicle screw placement |
US6839594B2 (en) | 2001-04-26 | 2005-01-04 | Biocontrol Medical Ltd | Actuation and control of limbs through motor nerve stimulation |
US20030105503A1 (en) * | 2001-06-08 | 2003-06-05 | Nuvasive, Inc. | Relative nerve movement and status detection system and method |
US6855105B2 (en) * | 2001-07-11 | 2005-02-15 | Jackson, Iii Avery M. | Endoscopic pedicle probe |
US6926728B2 (en) | 2001-07-18 | 2005-08-09 | St. Francis Medical Technologies, Inc. | Curved dilator and method |
EP1435828A4 (en) * | 2001-09-25 | 2009-11-11 | Nuvasive Inc | System and methods for performing surgical procedures and assessments |
US20030078618A1 (en) | 2001-10-19 | 2003-04-24 | Fey Kate E. | System and method for removing implanted devices |
EP1443859A4 (en) * | 2001-10-24 | 2006-03-22 | Cutting Edge Surgical Inc | Intraosteal ultrasound during surgical implantation |
US7664544B2 (en) * | 2002-10-30 | 2010-02-16 | Nuvasive, Inc. | System and methods for performing percutaneous pedicle integrity assessments |
US6916330B2 (en) * | 2001-10-30 | 2005-07-12 | Depuy Spine, Inc. | Non cannulated dilators |
US7824410B2 (en) | 2001-10-30 | 2010-11-02 | Depuy Spine, Inc. | Instruments and methods for minimally invasive spine surgery |
US7214197B2 (en) | 2001-11-06 | 2007-05-08 | Prass Richard L | Intraoperative neurophysiological monitoring system |
US6730021B2 (en) * | 2001-11-07 | 2004-05-04 | Computer Motion, Inc. | Tissue spreader with force measurement, force indication or force limitation |
FR2835732B1 (en) | 2002-02-11 | 2004-11-12 | Spinevision | DEVICE FOR TRACKING THE PENETRATION OF A PENETRATION MEANS IN ANATOMICAL ELEMENTS |
US7294127B2 (en) | 2002-03-05 | 2007-11-13 | Baylis Medical Company Inc. | Electrosurgical tissue treatment method |
US7258688B1 (en) | 2002-04-16 | 2007-08-21 | Baylis Medical Company Inc. | Computerized electrical signal generator |
US8147421B2 (en) * | 2003-01-15 | 2012-04-03 | Nuvasive, Inc. | System and methods for determining nerve direction to a surgical instrument |
US7153279B2 (en) | 2002-07-09 | 2006-12-26 | George Washington University | Brain retraction sensor |
US6916294B2 (en) | 2002-07-09 | 2005-07-12 | George Washington University | Brain retraction sensor |
AU2002950769A0 (en) | 2002-08-06 | 2002-09-12 | Neopraxis Pty Ltd | A method and system for inserting an electrode |
US7282033B2 (en) | 2002-09-04 | 2007-10-16 | Urmey William F | Positioning system for a nerve stimulator needle |
US8137284B2 (en) * | 2002-10-08 | 2012-03-20 | Nuvasive, Inc. | Surgical access system and related methods |
US20040225228A1 (en) * | 2003-05-08 | 2004-11-11 | Ferree Bret A. | Neurophysiological apparatus and procedures |
AU2004263152B2 (en) * | 2003-08-05 | 2009-08-27 | Nuvasive, Inc. | Systems and methods for performing dynamic pedicle integrity assessments |
EP1680177B1 (en) | 2003-09-25 | 2017-04-12 | NuVasive, Inc. | Surgical access system |
WO2006012535A1 (en) | 2004-07-23 | 2006-02-02 | North Carolina State University | Force-determining retraction device and associated method |
US20060052856A1 (en) * | 2004-09-08 | 2006-03-09 | Kim Daniel H | Stimulation components |
EP2409641B1 (en) | 2005-02-02 | 2017-07-05 | NuVasive, Inc. | System for performing neurophysiologic assessments during spine surgery |
USD574955S1 (en) | 2007-06-22 | 2008-08-12 | Vioptix, Inc. | Portion of nerve root retractor with sensor |
-
2006
- 2006-07-20 US US11/490,717 patent/US8740783B2/en active Active
-
2010
- 2010-06-16 US US12/817,161 patent/US20100317989A1/en not_active Abandoned
-
2014
- 2014-06-03 US US14/294,304 patent/US20140288389A1/en not_active Abandoned
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4795998A (en) * | 1984-05-04 | 1989-01-03 | Raychem Limited | Sensor array |
US5201325A (en) * | 1989-09-01 | 1993-04-13 | Andronic Devices Ltd. | Advanced surgical retractor |
US5085226A (en) * | 1990-05-30 | 1992-02-04 | Trustees Of Boston University | Force monitoring apparatus for back muscles |
US5163328A (en) * | 1990-08-06 | 1992-11-17 | Colin Electronics Co., Ltd. | Miniature pressure sensor and pressure sensor arrays |
US5253656A (en) * | 1991-05-23 | 1993-10-19 | Rincoe Richard G | Apparatus and method for monitoring contact pressure between body parts and contact surfaces |
US6500210B1 (en) * | 1992-09-08 | 2002-12-31 | Seattle Systems, Inc. | System and method for providing a sense of feel in a prosthetic or sensory impaired limb |
US5924984A (en) * | 1997-01-30 | 1999-07-20 | University Of Iowa Research Foundation | Anorectal probe apparatus having at least one muscular activity sensor |
US6511427B1 (en) * | 2000-03-10 | 2003-01-28 | Acuson Corporation | System and method for assessing body-tissue properties using a medical ultrasound transducer probe with a body-tissue parameter measurement mechanism |
US20020194934A1 (en) * | 2001-06-26 | 2002-12-26 | Taylor Geoffrey L. | Pressure measurement sensor with piezoresistive thread lattice |
WO2003005887A2 (en) * | 2001-07-11 | 2003-01-23 | Nuvasive, Inc. | System and methods for determining nerve proximity, direction, and pathology during surgery |
US20030212335A1 (en) * | 2002-03-02 | 2003-11-13 | Huang Herb H. | Pulse diagnostic system |
WO2003094744A1 (en) * | 2002-05-09 | 2003-11-20 | Tyco Healthcare Group Lp | Endoscopic organ retractor and method of using the same |
US20040068203A1 (en) * | 2002-10-03 | 2004-04-08 | Scimed Life Systems, Inc. | Sensing pressure |
US20040230131A1 (en) * | 2003-02-21 | 2004-11-18 | Kassab Ghassan S. | System and method for measuring cross-sectional areas and pressure gradients in luminal organs |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11026627B2 (en) | 2013-03-15 | 2021-06-08 | Cadwell Laboratories, Inc. | Surgical instruments for determining a location of a nerve during a procedure |
US11963784B2 (en) | 2013-11-07 | 2024-04-23 | Safeop Surgical, Inc. | Systems and methods for detecting nerve function |
US10092762B2 (en) | 2014-08-15 | 2018-10-09 | Axonics Modulation Technologies, Inc. | Integrated electromyographic clinician programmer for use with an implantable neurostimulator |
US9555246B2 (en) | 2014-08-15 | 2017-01-31 | Axonics Modulation Technologies, Inc. | Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder |
US11730411B2 (en) | 2014-08-15 | 2023-08-22 | Axonics, Inc. | Methods for determining neurostimulation electrode configurations based on neural localization |
US10406369B2 (en) | 2014-08-15 | 2019-09-10 | Axonics Modulation Technologies, Inc. | Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder |
US10729903B2 (en) | 2014-08-15 | 2020-08-04 | Axonics Modulation Technologies, Inc. | Methods for determining neurostimulation electrode configurations based on neural localization |
US9561372B2 (en) | 2014-08-15 | 2017-02-07 | Axonics Modulation Technologies, Inc. | Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder |
US11116985B2 (en) | 2014-08-15 | 2021-09-14 | Axonics, Inc. | Clinician programmer for use with an implantable neurostimulation lead |
US9533155B2 (en) | 2014-08-15 | 2017-01-03 | Axonics Modulation Technologies, Inc. | Methods for determining neurostimulation electrode configurations based on neural localization |
US11497916B2 (en) | 2014-08-15 | 2022-11-15 | Axonics, Inc. | Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder |
US9855423B2 (en) | 2014-08-15 | 2018-01-02 | Axonics Modulation Technologies, Inc. | Systems and methods for neurostimulation electrode configurations based on neural localization |
US12048567B2 (en) | 2015-05-04 | 2024-07-30 | Safeop Surgical, Inc. | System, method, and computer algorithm for measuring, displaying, and accurately detecting changes in electrophysiological evoked potentials |
US11986321B2 (en) | 2016-09-22 | 2024-05-21 | Safeop Surgical, Inc. | System and method for detecting and removing periodic non-physiological artifact from evoked potentials |
US11177610B2 (en) | 2017-01-23 | 2021-11-16 | Cadwell Laboratories, ino. | Neuromonitoring connection system |
US11949188B2 (en) | 2017-01-23 | 2024-04-02 | Cadwell Laboratories, Inc. | Methods for concurrently forming multiple electrical connections in a neuro-monitoring system |
US11963775B2 (en) | 2017-03-22 | 2024-04-23 | Safeop Surgical, Inc. | Medical systems and methods for detecting changes in electrophysiological evoked potentials |
US11701047B2 (en) | 2017-06-16 | 2023-07-18 | Alphatec Spine, Inc. | Systems, methods, and devices for detecting the threshold of nerve-muscle response using variable frequency of stimulation |
US11992339B2 (en) | 2018-05-04 | 2024-05-28 | Cadwell Laboratories, Inc. | Systems and methods for dynamic neurophysiological stimulation |
US11998338B2 (en) | 2018-05-04 | 2024-06-04 | Cadwell Laboratories, Inc. | Systems and methods for dynamically switching output port cathode and anode designations |
US11253182B2 (en) | 2018-05-04 | 2022-02-22 | Cadwell Laboratories, Inc. | Apparatus and method for polyphasic multi-output constant-current and constant-voltage neurophysiological stimulation |
US11443649B2 (en) | 2018-06-29 | 2022-09-13 | Cadwell Laboratories, Inc. | Neurophysiological monitoring training simulator |
US11978360B2 (en) | 2018-06-29 | 2024-05-07 | Cadwell Laboratories, Inc. | Systems and methods for neurophysiological simulation |
US11848090B2 (en) | 2019-05-24 | 2023-12-19 | Axonics, Inc. | Trainer for a neurostimulator programmer and associated methods of use with a neurostimulation system |
US11439829B2 (en) | 2019-05-24 | 2022-09-13 | Axonics, Inc. | Clinician programmer methods and systems for maintaining target operating temperatures |
Also Published As
Publication number | Publication date |
---|---|
US20100317989A1 (en) | 2010-12-16 |
US20070021682A1 (en) | 2007-01-25 |
US8740783B2 (en) | 2014-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8740783B2 (en) | System and methods for performing neurophysiologic assessments with pressure monitoring | |
US11617562B2 (en) | System and methods for nerve monitoring | |
US11793447B2 (en) | System and methods for performing neurophysiologic assessments during spine surgery | |
US10507120B2 (en) | Systems and methods for performing surgical procedures and assessments | |
US8989866B2 (en) | System and methods for assessing the neuromuscular pathway prior to nerve testing | |
US12127877B2 (en) | System and methods for nerve monitoring |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NUVASIVE, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GHARIB, JAMES;FARQUHAR, ALLEN;MARTINELLI, SCOT;AND OTHERS;SIGNING DATES FROM 20101011 TO 20101020;REEL/FRAME:033015/0649 |
|
AS | Assignment |
Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, CALIFORNIA Free format text: NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS;ASSIGNORS:NUVASIVE, INC.;IMPULSE MONITORING, INC.;REEL/FRAME:040634/0404 Effective date: 20160208 Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, CA Free format text: NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS;ASSIGNORS:NUVASIVE, INC.;IMPULSE MONITORING, INC.;REEL/FRAME:040634/0404 Effective date: 20160208 |
|
AS | Assignment |
Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, TE Free format text: NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS;ASSIGNORS:NUVASIVE, INC.;BIOTRONIC NATIONAL, LLC;NUVASIVE CLINICAL SERVICES MONITORING, INC.;AND OTHERS;REEL/FRAME:042490/0236 Effective date: 20170425 Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, TEXAS Free format text: NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS;ASSIGNORS:NUVASIVE, INC.;BIOTRONIC NATIONAL, LLC;NUVASIVE CLINICAL SERVICES MONITORING, INC.;AND OTHERS;REEL/FRAME:042490/0236 Effective date: 20170425 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT, NORTH CAROLINA Free format text: SECURITY INTEREST;ASSIGNORS:NUVASIVE, INC.;NUVASIVE CLINICAL SERVICES MONITORING, INC.;NUVASIVE CLINICAL SERVICES, INC.;AND OTHERS;REEL/FRAME:052918/0595 Effective date: 20200224 |